The Toro Company (TTC) 10-Q 4 Mar 21 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Jan. 29, 2021	Feb. 25, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 29, 2021
Document Transition Report	false
Entity File Number	1-8649
Entity Registrant Name	THE TORO COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-0580470
Entity Address, Address Line One	8111 Lyndale Avenue South
Entity Address, City or Town	Bloomington
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55420-1196
City Area Code	952
Local Phone Number	888-8801
Title of 12(b) Security	Common Stock, par value $1.00 per share
Trading Symbol	TTC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		107,620,141
Entity Central Index Key	0000737758
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Income Statement [Abstract]
Net sales	$ 872,986	$ 767,483
Cost of sales	557,950	479,395
Gross profit	315,036	288,088
Selling, general and administrative expense	173,571	196,959
Operating earnings	141,465	91,129
Interest expense	(7,522)	(8,156)
Other income, net	1,883	3,166
Earnings before income taxes	135,826	86,139
Provision for income taxes	24,545	16,048
Net earnings	$ 111,281	$ 70,091
Basic net earnings per share of common stock (usd per share)	$ 1.03	$ 0.65
Diluted net earnings per share of common stock (usd per share)	$ 1.02	$ 0.65
Weighted-average number of shares of common stock outstanding — Basic (in shares)	108,122	107,423
Weighted-average number of shares of common stock outstanding — Diluted (in shares)	109,194	108,655

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Statement of Comprehensive Income [Abstract]
Net earnings	$ 111,281	$ 70,091
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	10,396	(724)
Derivative instruments, net of tax of $(2,792) and $189, respectively	(8,310)	652
Other comprehensive income (loss), net of tax	2,086	(72)
Comprehensive income	$ 113,367	$ 70,019

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Statement of Comprehensive Income [Abstract]
Derivative instruments, tax	$ (2,792)	$ 189

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
ASSETS
Cash and cash equivalents	$ 433,394	$ 479,892	$ 108,914
Receivables, net	306,865	261,135	321,192
Inventories, net	675,307	652,433	738,960
Prepaid expenses and other current assets	41,177	34,188	51,442
Total current assets	1,456,743	1,427,648	1,220,508
Property, plant, and equipment, net	457,147	467,919	431,253
Goodwill	422,163	424,075	362,136
Other intangible assets, net	410,587	408,305	347,643
Right-of-use assets	75,467	78,752	73,137
Investment in finance affiliate	22,955	19,745	25,455
Deferred income taxes	9,658	6,466	6,161
Other assets	20,418	20,318	25,316
Total assets	2,875,138	2,853,228	2,491,609
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt	9,992	99,873	113,903
Accounts payable	364,361	363,953	348,003
Accrued liabilities	429,820	376,524	348,027
Short-term lease liabilities	15,368	15,447	14,374
Total current liabilities	819,541	855,797	824,307
Long-term debt, less current portion	691,356	691,250	601,016
Long-term lease liabilities	63,469	66,641	62,015
Deferred income taxes	71,970	70,435	50,676
Other long-term liabilities	$ 49,080	$ 54,277	$ 41,545
Preferred stock, issued (in shares)	0	0	0
Preferred stock, outstanding (in shares)	0	0	0
Preferred stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Stockholders’ equity:
Preferred stock, par value $1.00 per share, authorized 1,000,000 voting and 850,000 non-voting shares, none issued and outstanding	$ 0	$ 0	$ 0
Common stock, par value $1.00 per share, authorized 175,000,000 shares; issued and outstanding 107,613,431 shares as of January 29, 2021, 106,977,274 shares as of January 31, 2020, and 107,582,670 shares as of October 31, 2020	107,613	107,583	106,977
Retained earnings	1,104,285	1,041,507	837,194
Accumulated other comprehensive loss	(32,176)	(34,262)	(32,121)
Total stockholders’ equity	1,179,722	1,114,828	912,050
Total liabilities and stockholders’ equity	$ 2,875,138	$ 2,853,228	$ 2,491,609

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Preferred stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Preferred stock, issued (in shares)	0	0	0
Preferred stock, outstanding (in shares)	0	0	0
Common stock
Common stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Common stock, authorized (in shares)	175,000,000	175,000,000	175,000,000
Common stock, issued (in shares)	107,613,431	107,582,670	106,977,274
Common stock, outstanding (in shares)	107,613,431	107,582,670	106,977,274
Voting preferred stock
Preferred stock
Preferred stock, authorized (in shares)	1,000,000	1,000,000	1,000,000
Non-voting preferred stock
Preferred stock
Preferred stock, authorized (in shares)	850,000	850,000	850,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Cash flows from operating activities:
Net earnings	$ 111,281	$ 70,091
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Non-cash income from finance affiliate	(1,283)	(1,751)
(Contributions to) distributions from finance affiliate, net	(1,927)	442
Depreciation of property, plant and equipment	19,173	18,089
Amortization of other intangible assets	4,894	4,714
Fair value step-up adjustment to acquired inventory	0	470
Stock-based compensation expense	4,516	3,960
Deferred income taxes	1,232	141
Other	1,080	175
Changes in operating assets and liabilities, net of the effect of acquisitions:
Receivables, net	(46,159)	(53,044)
Inventories, net	(25,594)	(88,557)
Prepaid expenses and other assets	(2,794)	237
Accounts payable, accrued liabilities, deferred revenue and other liabilities	30,606	21,734
Net cash provided by (used in) operating activities	95,025	(23,299)
Cash flows from investing activities:
Purchases of property, plant and equipment	(10,504)	(11,821)
Asset acquisition, net of cash acquired	(4,542)	0
Proceeds from asset disposals	74	25
Proceeds from sale of a business	12,886	0
Net cash used in investing activities	(2,086)	(11,796)
Cash flows from financing activities:
Borrowings under debt arrangements	0	82,025
Repayments under debt arrangements	(90,000)	(68,025)
Proceeds from exercise of stock options	7,714	6,710
Payments of withholding taxes for stock awards	(941)	(1,361)
Purchases of TTC common stock	(31,351)	0
Dividends paid on TTC common stock	(28,411)	(26,856)
Net cash used in financing activities	(142,989)	(7,507)
Effect of exchange rates on cash and cash equivalents	3,552	(312)
Net decrease in cash and cash equivalents	(46,498)	(42,914)
Cash and cash equivalents as of the beginning of the fiscal period	479,892	151,828
Cash and cash equivalents as of the end of the fiscal period	$ 433,394	$ 108,914

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2019	$ 859,578	$ 106,742	$ 784,885	$ (32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,856)		(26,856)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	4,142	253	3,889
Stock-based compensation expense	3,960		3,960
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(1,361)	(18)	(1,343)
Other comprehensive income	(72)			(72)
Net earnings	70,091		70,091
Balance at end of period at Jan. 31, 2020	912,050	106,977	837,194	(32,121)
Balance at beginning of period at Oct. 31, 2020	1,114,828	107,583	1,041,507	(34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,411)		(28,411)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	6,229	350	5,879
Stock-based compensation expense	4,516		4,516
Contribution of stock to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(32,292)	(343)	(31,949)
Other comprehensive income	2,086			2,086
Net earnings	111,281		111,281
Balance at end of period at Jan. 29, 2021	$ 1,179,722	$ 107,613	$ 1,104,285	$ (32,176)

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Statement of Stockholders' Equity [Abstract]
Cash dividends paid on common stock (in dollars per share)	$ 0.2625	$ 0.25
Issuance of share-based payment awards (in shares)	351,178	351,501
Contribution to a deferred compensation trust (in shares)	22,700
Purchase of shares of common stock (in shares)	343,117	17,740

Basis of Presentation

Basis of Presentation	3 Months Ended
	Jan. 29, 2021
Accounting Policies [Abstract]
Basis of Presentation	1 Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States ("U.S.") generally accepted accounting principles ("GAAP") for complete financial statements. Unless the context indicates otherwise, the terms "company," "TTC," "we," "our," or "us" refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements. In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's Consolidated Financial Position, Results of Operations, and Cash Flows for the periods presented. Due to seasonality within the industries in which the company's business operates and the current COVID-19 pandemic, among other factors, operating results for the three months ended January 29, 2021 cannot be annualized to determine the expected results for the fiscal year ending October 31, 2021. The company’s fiscal year ends on October 31, and quarterly results are reported based on three-month periods that generally end on the Friday closest to the calendar quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end. For further information regarding the company's basis of presentation, refer to the Consolidated Financial Statements and Notes to Consolidated Financial Statements included in the company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2020. The policies described in that report are used for preparing the company's quarterly reports on Form 10-Q. Impact of COVID-19 Pandemic In March 2020, the World Health Organization declared the novel coronavirus ("COVID-19" or "the pandemic") outbreak a global pandemic. COVID-19 has negatively impacted public health and portions of the global economy, disrupted global supply chains, and created volatility in financial markets. The continuing implications of COVID-19 on the company remain uncertain and will depend on certain future developments, including the duration, scope, and severity of the pandemic; its impact on the company's employees, customers, and suppliers; the range of government mandated restrictions and other measures; and the success of the deployment of approved COVID-19 vaccines and their effectiveness. This uncertainty could have a material impact on accounting estimates and assumptions utilized to prepare the Condensed Consolidated Financial Statements in future reporting periods, which could result in a material adverse impact on the company's Consolidated Financial Position, Results of Operations, and Cash Flows. Accounting Policies and Estimates In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty accruals, allowances for current expected credit losses, pension accruals, self-insurance accruals, legal accruals, right-of-use assets and lease liabilities, useful lives for tangible and finite-lived intangible assets, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, and valuations of the assets acquired and liabilities assumed in a business combination, when applicable. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made and are generally derived from management's understanding and analysis of the relevant and current circumstances, historical experience, and actuarial and other independent external third-party specialist valuations, when applicable. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the economic environment. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, including those impacted by the COVID-19 pandemic, actual amounts could differ significantly from those estimated at the time the Condensed Consolidated Financial Statements are prepared. New Accounting Pronouncements Adopted In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which modifies the measurement approach for credit losses on financial assets measured on an amortized cost basis from an 'incurred loss' method to an 'expected loss' method. Such modification of the measurement approach for credit losses eliminates the requirement that a credit loss be considered probable, or incurred, to impact the valuation of a financial asset measured on an amortized cost basis. The amended guidance requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions, and a reasonable and supportable forecast that affects the collectability of the related financial asset. This amendment affects trade receivables, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope of this amendment that have the contractual right to receive cash. The amended guidance was adopted in the first quarter of fiscal 2021, under the modified retrospective transition method. The adoption of the amended guidance did not have a material impact on the company's Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) - Changes to the Disclosure Requirements for Fair Value Measurement , which modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The amended guidance was adopted in the first quarter of fiscal 2021 and did not have a material impact on the company's Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans (Topic 715) , which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. The amended guidance was adopted in the first quarter of fiscal 2021 and did not have a material impact on the company's Condensed Consolidated Financial Statements. New Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The amended guidance also clarifies and simplifies other aspects of the accounting for income taxes under accounting standards codification Topic 740, Income Taxes . The amended guidance will become effective in the first quarter of fiscal 2022. Early adoption is permitted. The company is currently evaluating the impact of this new standard on its Condensed Consolidated Financial Statements. In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarified that before applying or upon discontinuing the equity method of accounting for an investment in equity securities, an entity should consider observable transactions that require it to apply or discontinue the equity method of accounting for the purposes of applying the fair value measurement alternative. The amended guidance will become effective in the first quarter of fiscal 2022. Early adoption is permitted. The company is currently evaluating the impact of this standard on its Condensed Consolidated Financial Statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional guidance to ease the potential burden of accounting for reference rate reform due to the cessation of the London Interbank Offered Rate, commonly referred to as "LIBOR." The temporary guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, relationships, and transactions affected by reference rate reform if certain criteria are met. The provisions of the temporary optional guidance are only available until December 31, 2022, when the reference rate reform activity is expected to be substantially complete. When adopted, entities may apply the provisions as of the beginning of the reporting period when the election is made. The company is currently evaluating the impact of this standard on its Condensed Consolidated Financial Statements and has yet to elect an adoption date. The company believes that all other recently issued accounting pronouncements from the FASB that the company has not noted above, will not have a material impact on its Condensed Consolidated Financial Statements or do not apply to its operations.

Business Combination

Business Combination	3 Months Ended
	Jan. 29, 2021
Business Combinations [Abstract]
Business Combination	2 Business Combination Venture Products, Inc. ("Venture Products") On March 2, 2020, the company completed its acquisition of Venture Products, the manufacturer of Ventrac-branded products. Venture Products designs, manufactures, and markets articulating turf, landscape, and snow and ice management equipment for grounds, landscape contractor, golf, municipal, and rural acreage customers and provides innovative product offerings that broadened and strengthened the company's Professional segment and expanded its dealer network. On the closing date of the acquisition, the company paid preliminary merger consideration of $165.9 million, which consisted of a cash payment of $136.4 million and a $29.5 million holdback to satisfy any indemnification or certain other obligations of Venture Products to the company. The preliminary merger consideration was subject to certain customary adjustments, which were finalized during the third quarter of fiscal 2020 and resulted in an aggregate merger consideration of $163.2 million. As a result, $4.5 million of the holdback set aside for such customary adjustments was released accordingly and the remaining holdback of $25.0 million is expected to expire throughout fiscal 2021. The company funded the cash payment with borrowings under its existing unsecured senior revolving credit facility. For additional information regarding the company's unsecured senior revolving credit facility, refer to Note 6, Indebtedness . The company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the purchase price was allocated to the acquired net tangible and intangible assets of Venture Products based on their fair values as of the closing date of the acquisition. Such fair values are based on internal company and independent external third-party valuations. As of January 29, 2021, the company completed its process for measuring the fair values of the acquired assets and liabilities assumed based on information available as of the closing date of the acquisition. The following table summarizes the allocation of the purchase price to the fair values assigned to the Venture Products assets acquired and liabilities assumed: (Dollars in thousands) March 2, 2020 Cash and cash equivalents $ 3,476 Receivables 6,342 Inventories 23,000 Prepaid expenses and other current assets 239 Property, plant and equipment 26,976 Goodwill 61,225 Other intangible assets: Finite-lived customer-related 19,100 Indefinite-lived trade name 56,200 Accounts payable (4,075) Accrued liabilities (5,196) Deferred income tax liabilities (20,586) Total fair value of net assets acquired 166,701 Less: cash and cash equivalents acquired (3,476) Total purchase price $ 163,225 The goodwill recognized is primarily attributable to the value of the workforce, the reputation of Venture Products, expected future cash flows, and expected synergies, including customer and dealer growth opportunities and integrating and expanding existing product lines. Key areas of expected cost synergies include increased purchasing power for commodities, components, parts, and accessories, and supply chain consolidation. The goodwill resulting from the Venture Products acquisition was recognized within the company's Professional segment and is non-deductible for tax purposes. During the first quarter of fiscal 2021, the company completed its valuation of income taxes to finalize the purchase price allocation, which resulted in a decrease to the carrying amount of goodwill of $1.0 million from the amounts reporting within the company's Annual Report on Form 10-K for the fiscal year ended October 31, 2020. Such purchase accounting adjustment did not impact the company's Condensed Consolidated Statements of Earnings for the three month period ended January 29, 2021. The allocation of the purchase price to the net assets acquired resulted in the recognition of $75.3 million of other intangible assets as of the closing date of the acquisition. The fair values of the acquired trade name and customer-related intangible assets were determined using the income approach whereby an intangible asset's fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. The useful lives of the other intangible assets were determined based on the period of expected cash flows used to measure the fair value of the intangible assets adjusted as appropriate for entity-specific factors including legal, regulatory, contractual, competitive, economic, and/or other factors that may limit the useful life of the respective intangible asset. The fair value of the indefinite-lived trade name was determined using the relief

Segment Data

Segment Data	3 Months Ended
	Jan. 29, 2021
Segment Reporting [Abstract]
Segment Data	3 Segment Data The company's businesses are organized, managed, and internally grouped into segments based on similarities in products and services. Segment selection is based on the manner in which management organizes segments for making operating and investment decisions and assessing performance. The company has identified eleven operating segments and has aggregated certain of those segments into two reportable segments: Professional and Residential. The aggregation of the company's segments is based on the segments having the following similarities: economic characteristics, types of products and services, types of production processes, type or class of customers, and method of distribution. The company's remaining activities are presented as "Other" due to their insignificance. As further described in Note 7, Divestiture , during the first quarter of fiscal 2021, the company completed the sale of its Northeastern U.S. distribution company. As a result, for the three month period ended January 29, 2021, the company's Other activities consisted of the company's wholly-owned domestic distribution company, the company's corporate activities, and the elimination of intersegment revenues and expenses. For the three month period ended January 31, 2020, the company's Other activities consisted of the company's wholly-owned domestic distribution companies, the company's corporate activities, and the elimination of intersegment revenues and expenses. The following tables present summarized financial information concerning the company’s reportable segments and Other activities: (Dollars in thousands) Three Months Ended January 29, 2021 Professional Residential Other Total Net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Intersegment gross sales (eliminations) 6,642 16 (6,658) — Earnings (loss) before income taxes 116,816 32,108 (13,098) 135,826 Total assets $ 1,952,536 $ 345,185 $ 577,417 $ 2,875,138 (Dollars in thousands) Three Months Ended January 31, 2020 Professional Residential Other Total Net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483 Intersegment gross sales (eliminations) 8,771 27 (8,798) — Earnings (loss) before income taxes 102,474 21,566 (37,901) 86,139 Total assets $ 1,853,739 $ 324,089 $ 313,781 $ 2,491,609 The following table presents the details of operating loss before income taxes for the company's Other activities: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Corporate expenses $ (11,303) $ (32,442) Interest expense (7,522) (8,156) Earnings from wholly-owned domestic distribution companies and other income, net 5,727 2,697 Total operating loss $ (13,098) $ (37,901)

Revenue

Revenue	3 Months Ended
	Jan. 29, 2021
Revenue from Contract with Customer [Abstract]
Revenue	4 Revenue The following tables disaggregate the company's reportable segment net sales by major product type and geographic market (in thousands): Three Months Ended January 29, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 575,775 $ 205,923 $ 3,942 $ 785,640 Irrigation 74,448 11,777 1,121 87,346 Total net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Revenue by geographic market: United States $ 501,860 $ 174,382 $ 5,063 $ 681,305 International Countries 148,363 43,318 — 191,681 Total net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Three Months Ended January 31, 2020 Professional Residential Other Total Revenue by product type: Equipment $ 523,909 $ 152,458 $ 5,525 $ 681,892 Irrigation 70,812 13,390 1,389 85,591 Total net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483 Revenue by geographic market: United States $ 454,396 $ 130,338 $ 6,914 $ 591,648 International Countries 140,325 35,510 — 175,835 Total net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483 Contract Liabilities Contract liabilities relate to deferred revenue recognized for cash consideration received at contract inception in advance of the company's performance under the respective contract and generally relate to the sale of separately priced extended warranty contracts, service contracts, and non-refundable customer deposits. The company recognizes revenue over the term of the contract in proportion to the costs expected to be incurred in satisfying the performance obligations under the separately priced extended warranty and service contracts. For non-refundable customer deposits, the company recognizes revenue as of the point in time in which the performance obligation has been satisfied under the contract with the customer, which typically occurs upon change in control at the time a product is shipped. As of both January 29, 2021 and October 31, 2020, $21.9 million of deferred revenue associated with outstanding separately priced extended warranty contracts, service contracts, and non-refundable customer deposits was reported within accrued liabilities and other long-term liabilities in the Condensed Consolidated Balance Sheets. For the three months ended January 29, 2021, the company recognized $2.5 million of the October 31, 2020 deferred revenue balance within net sales in the Condensed Consolidated Statements of Earnings. The company expects to recognize approximately $7.5 million of the October 31, 2020 deferred revenue amount within net sales throughout the remainder of fiscal 2021, $6.8 million in fiscal 2022, and $5.1 million thereafter.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets, Net	3 Months Ended
	Jan. 29, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets, Net	5 Goodwill and Other Intangible Assets, Net Goodwill The changes in the carrying amount of goodwill by reportable segment for the first three months of fiscal 2021 were as follows: (Dollars in thousands) Professional Residential Other Total Balance as of October 31, 2020 $ 412,061 $ 10,480 $ 1,534 $ 424,075 Purchase price allocation adjustment (1,027) — — (1,027) Goodwill divested — — (1,534) (1,534) Translation adjustments 518 131 — 649 Balance as of January 29, 2021 $ 411,552 $ 10,611 $ — $ 422,163 Other Intangible Assets, Net The components of other intangible assets, net as of January 29, 2021 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,123) $ 4,152 Non-compete agreements 5.5 6,908 (6,851) 57 Customer-related 18.2 239,816 (51,747) 188,069 Developed technology 7.7 59,017 (36,230) 22,787 Trade names 15.3 7,563 (2,684) 4,879 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.3 335,969 (116,025) 219,944 Indefinite-lived - trade names 190,643 — 190,643 Total other intangible assets, net $ 526,612 $ (116,025) $ 410,587 The components of other intangible assets, net as of January 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,238 $ (13,307) $ 4,931 Non-compete agreements 5.5 6,875 (6,798) 77 Customer-related 18.4 220,364 (36,970) 183,394 Developed technology 7.6 51,902 (32,264) 19,638 Trade names 15.4 7,485 (2,208) 5,277 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 309,254 (95,937) 213,317 Indefinite-lived - trade names 134,326 — 134,326 Total other intangible assets, net $ 443,580 $ (95,937) $ 347,643 The components of other intangible assets, net as of October 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,257 $ (13,919) $ 4,338 Non-compete agreements 5.5 6,892 (6,831) 61 Customer-related 18.2 239,634 (48,005) 191,629 Developed technology 7.6 51,995 (35,208) 16,787 Trade names 15.4 7,530 (2,552) 4,978 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 328,698 (110,905) 217,793 Indefinite-lived - trade names 190,512 — 190,512 Total other intangible assets, net $ 519,210 $ (110,905) $ 408,305 Amortization expense for finite-lived intangible assets during the first quarter of fiscal 2021 and fiscal 2020 was $4.9 million and $4.7 million, respectively. Estimated amortization expense for the remainder of fiscal 2021 and succeeding fiscal years is as follows: fiscal 2021 (remainder), $15.7 million; fiscal 2022, $19.3 million; fiscal 2023, $17.6 million; fiscal 2024, $16.5 million; fiscal 2025, $14.9 million; fiscal 2026, $14.2 million; and after fiscal 2026, $121.7 million.

Indebtedness

Indebtedness	3 Months Ended
	Jan. 29, 2021
Debt Disclosure [Abstract]
Indebtedness	6 Indebtedness The following is a summary of the company's indebtedness: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Revolving credit facility $ — $ 14,000 $ — $200 million term loan 100,000 100,000 100,000 $300 million term loan 180,000 180,000 180,000 $190 million term loan — — 90,000 3.81% series A senior notes 100,000 100,000 100,000 3.91% series B senior notes 100,000 100,000 100,000 7.8% debentures 100,000 100,000 100,000 6.625% senior notes 123,993 123,931 123,978 Less: unamortized discounts, debt issuance costs, and deferred charges 2,645 3,012 2,855 Total long-term debt 701,348 714,919 791,123 Less: current portion of long-term debt 9,992 113,903 99,873 Long-term debt, less current portion $ 691,356 $ 601,016 $ 691,250 Principal payments required on the company's outstanding indebtedness, based on the maturity dates defined within the company's debt arrangements, for the remainder of fiscal 2021 and succeeding five fiscal years are as follows: fiscal 2021 (remainder), $0.0 million; fiscal 2022, $109.0 million; fiscal 2023, $18.0 million; fiscal 2024, $153.0 million; fiscal 2025, $0.0 million; fiscal 2026, $0.0 million; and after fiscal 2026, $425.0 million.

Divestiture

Divestiture	3 Months Ended
	Jan. 29, 2021
Discontinued Operations and Disposal Groups [Abstract]
Divestiture	7 Divestiture On November 2, 2020, in the first quarter of fiscal 2021, the company completed the sale of its Northeastern U.S. distribution company. The divestiture was not material based on the company's Consolidated Financial Condition and Results of Operations.

Inventories

Inventories	3 Months Ended
	Jan. 29, 2021
Inventory Disclosure [Abstract]
Inventories	8 Inventories Inventories are valued at the lower of cost or net realizable value, with cost determined by the first-in, first-out ("FIFO") method for a majority of the company's inventories and the last-in, first-out ("LIFO") and average cost methods for all other inventories. The company records an inventory valuation adjustment for excess, slow-moving, and obsolete inventory that is equal to the excess of the cost of the inventory over the estimated net realizable value or market value for the inventory depending on the inventory costing method. Such inventory valuation adjustment is based on a review and comparison of current inventory levels to planned production, as well as planned and historical sales of the inventory. The inventory valuation adjustment to net realizable value or market value establishes a new cost basis of the inventory that cannot be subsequently reversed. Inventories were as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Raw materials and work in process $ 226,979 $ 188,235 $ 168,759 Finished goods and service parts 530,415 632,796 565,761 Total FIFO value 757,394 821,031 734,520 Less: adjustment to LIFO value 82,087 82,071 82,087 Total inventories, net $ 675,307 $ 738,960 $ 652,433

Property and Depreciation

Property and Depreciation	3 Months Ended
	Jan. 29, 2021
Property, Plant and Equipment [Abstract]
Property and Depreciation	9 Property and Depreciation Property, plant, and equipment assets are carried at cost less accumulated depreciation. The company generally accounts for depreciation of property, plant, and equipment utilizing the straight-line method over the estimated useful lives of the assets. Buildings, land improvements, and leasehold improvements are generally depreciated over 10 to 40 years, machinery and equipment are generally depreciated over two three two Property, plant and equipment was as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Land and land improvements $ 56,808 $ 55,602 $ 57,387 Buildings and leasehold improvements 299,566 276,705 301,848 Machinery and equipment 500,410 450,321 499,312 Tooling 231,728 216,541 231,142 Computer hardware and software 102,357 94,385 102,312 Construction in process 58,346 58,056 48,157 Property, plant, and equipment, gross 1,249,215 1,151,610 1,240,158 Less: accumulated depreciation 792,068 720,357 772,239 Property, plant, and equipment, net $ 457,147 $ 431,253 $ 467,919

Warranty Guarantees

Warranty Guarantees	3 Months Ended
	Jan. 29, 2021
Product Warranties Disclosures [Abstract]
Warranty Guarantees	10 Warranty Guarantees The company’s products are warranted to provide assurance that the product will function as expected and to ensure customer confidence in design, workmanship, and overall quality. Standard warranty coverage is generally provided for specified periods of time and on select products’ hours of usage, and generally covers parts, labor, and other expenses for non-maintenance repairs. In addition to the standard warranties offered by the company on its products, the company also sells separately priced extended warranty coverage on select products for a prescribed period after the original warranty period expires. For additional information on the contract liabilities associated with the company's separately priced extended warranties, refer to Note 4, Revenue . The company recognizes expense and provides an accrual for estimated future warranty costs at the time of sale and also establishes accruals for major rework campaigns. Warranty accruals are based primarily on the estimated number of products under warranty, historical average costs incurred to service warranty claims, the trend in the historical ratio of claims to sales, and the historical length of time between the sale and resulting warranty claim. The company periodically assesses the adequacy of its warranty accruals based on changes in these factors and records any necessary adjustments if actual claims experience indicates that adjustments are necessary. The changes in accrued warranties were as follows: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Beginning balance $ 107,121 $ 96,604 Provisions 16,695 14,031 Claims (15,186) (14,703) Changes in estimates 153 691 Ending balance $ 108,783 $ 96,623

Investment in Finance Affiliate

Investment in Finance Affiliate	3 Months Ended
	Jan. 29, 2021
Equity Method Investments and Joint Ventures [Abstract]
Investment in Finance Affiliate	11 Investment in Finance Affiliate The company and TCF Inventory Finance, Inc. ("TCFIF"), a subsidiary of TCF National Bank, are parties to the Red Iron joint venture ("Red Iron"), which was established primarily to provide inventory financing to certain distributors and dealers of certain of the company’s products in the U.S. These financing transactions are structured as an advance in the form of a payment by Red Iron to the company on behalf of a distributor or dealer with respect to invoices financed by Red Iron. These payments extinguish the obligation of the dealer or distributor to make payment to the company under the terms of the applicable invoice. The company has also entered into a limited inventory repurchase agreement with Red Iron, under which the company has agreed to repurchase certain repossessed products, up to a maximum aggregate amount of $7.5 million in a calendar year. The company's financial exposure under this limited inventory repurchase agreement is limited to the difference between the amount paid for repurchases of repossessed product and the amount received upon the subsequent resale of the repossessed product. The company has repurchased immaterial amounts of inventory under this limited inventory repurchase agreement for the three months ended January 29, 2021 and January 31, 2020. Under separate agreements between Red Iron and the dealers and distributors, Red Iron provides loans to the dealers and distributors for the advances paid by Red Iron to the company. The net amount of receivables financed for dealers and distributors under this arrangement for the three months ended January 29, 2021 and January 31, 2020 were $511.3 million and $405.1 million, respectively. As of January 29, 2021, Red Iron’s total assets were $458.5 million and total liabilities were $407.5 million. The total amount of receivables due from Red Iron to the company as of January 29, 2021, January 31, 2020, and October 31, 2020 were $13.1 million, $29.5 million and $12.6 million, respectively. The company owns 45 percent of Red Iron and TCFIF owns 55 percent of Red Iron. The company accounts for its investment in Red Iron under the equity method of accounting. At inception, the company and TCFIF each contributed a specified amount of the estimated cash required to enable Red Iron to purchase the company’s inventory financing receivables and to provide financial support for Red Iron’s inventory financing programs. Red Iron borrows the remaining requisite estimated cash utilizing a $625.0 million secured revolving credit facility established under a credit agreement between Red Iron and TCFIF. The company’s total investment in Red Iron as of January 29, 2021, January 31, 2020, and October 31, 2020 was $23.0 million, $25.5 million, and $19.7 million, respectively. The company has not guaranteed the outstanding indebtedness of Red Iron.

Stock-Based Compensation Plans

Stock-Based Compensation Plans	3 Months Ended
	Jan. 29, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation Plans	12 Stock-Based Compensation Plans Compensation costs related to stock-based compensation awards were as follows: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Stock option awards $ 2,058 $ 1,777 Performance share awards 827 548 Restricted stock unit awards 960 942 Unrestricted common stock awards 671 693 Total compensation cost for stock-based compensation awards $ 4,516 $ 3,960 Stock Option Awards Under The Toro Company Amended and Restated 2010 Equity and Incentive Plan, as amended and restated (the "2010 plan"), stock options are granted with an exercise price equal to the closing price of the company’s common stock on the date of grant, as reported by the New York Stock Exchange. Options are generally granted to executive officers, other employees, and non-employee members of the company’s Board of Directors ("Board") on an annual basis in the first quarter of the company’s fiscal year. Compensation cost equal to the grant date fair value is generally recognized for these awards over the vesting period. Compensation cost recognized for other employees not considered executive officers and non-employee members of the company's Board is net of estimated forfeitures, which are determined at the time of grant based on historical forfeiture experience. The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation method with the assumptions noted in the table below. The expected life is a significant assumption as it determines the period for which the risk-free interest rate, stock price volatility, and dividend yield must be applied. The expected life is the average length of time in which executive officers, other employees, and non-employee members of the company's Board are expected to exercise their stock options, which is primarily based on historical exercise experience. The company groups executive officers and non-employee members of the company's Board for valuation purposes based on similar historical exercise behavior. Expected stock price volatility is based on the daily movement of the company’s common stock over the most recent historical period equivalent to the expected life of the option. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate over the expected life at the time of grant. The expected dividend yield is estimated over the expected life based on the company’s historical cash dividends paid, expected future cash dividends and dividend yield, and expected changes in the company’s stock price. The table below illustrates the weighted-average valuation assumptions for options granted in the first three months of the following fiscal periods: Fiscal 2021 Fiscal 2020 Expected life of option in years 6.21 6.31 Expected stock price volatility 23.26% 19.38% Risk-free interest rate 0.55% 1.79% Expected dividend yield 0.86% 0.98% Per share weighted-average fair value at date of grant $19.38 $15.37 Performance Share Awards Under the 2010 plan, the company grants performance share awards to executive officers and other employees under which they are entitled to receive shares of the company’s common stock contingent on the achievement of performance goals of the company, which are generally measured over a three-year period. The number of shares of common stock a participant receives can be increased (up to 200 percent of target levels) or reduced (down to zero) based on the level of achievement of performance goals and will vest at the end of a three-year period. Performance share awards are generally granted on an annual basis in the first quarter of the company’s fiscal year. Compensation cost is recognized for these awards on a straight-line basis over the vesting period based on the per share fair value, which is equal to the closing price of the company's common stock on the date of grant, and the probability of achieving each performance goal. The per share weighted-average fair value of performance share awards granted during the first quarter of fiscal 2021 and 2020 was $90.59 and $77.33, respectively. Restricted Stock Unit Awards Under the 2010 plan, restricted stock unit awards are generally granted to certain employees that are not executive officers. Occasionally, restricted stock unit awards may be granted, including to executive officers, in connection with hiring, mid-year promotions, leadership transition, or retention. Compensation cost equal to the grant date fair value, net of estimated forfeitures, is recognized for these awards over the vesting period. The grant date fair value is equal to the closing price of the company's common stock on the date of grant multiplied by the number of shares subject to the restricted stock unit awards and estimated forfeitures are determined on the grant date based on historical forfeiture experience. The per share weighted-average fair value of restricted stock unit awards granted during the first three months of fiscal 2021 and 2020 was $91.51 and $77.08, respectively. Unrestricted Common Stock Awards

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Jan. 29, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity	13 Stockholders' Equity Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss ("AOCL"), net of tax, within the Condensed Consolidated Statements of Stockholders' Equity were as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Foreign currency translation adjustments $ 14,112 $ 31,749 $ 24,508 Pension benefits 5,106 4,861 5,106 Cash flow derivative instruments 12,958 (4,489) 4,648 Total accumulated other comprehensive loss $ 32,176 $ 32,121 $ 34,262 The components and activity of AOCL, net of tax, for the three months of fiscal 2021 and 2020 were as follows: (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2020 $ 24,508 $ 5,106 $ 4,648 $ 34,262 Other comprehensive (income) loss before reclassifications (10,396) — 6,312 (4,084) Amounts reclassified from AOCL — — 1,998 1,998 Net current period other comprehensive (income) loss (10,396) — 8,310 (2,086) Balance as of January 29, 2021 $ 14,112 $ 5,106 $ 12,958 $ 32,176 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2019 $ 31,025 $ 4,861 $ (3,837) $ 32,049 Other comprehensive loss before reclassifications 724 — 885 1,609 Amounts reclassified from AOCL — — (1,537) (1,537) Net current period other comprehensive (income) loss 724 — (652) 72 Balance as of January 31, 2020 $ 31,749 $ 4,861 $ (4,489) $ 32,121 For additional information on the components reclassified from AOCL to the respective line items in net earnings for derivative instruments refer to Note 17, Derivative Instruments and Hedging Activities .

Per Share Data

Per Share Data	3 Months Ended
	Jan. 29, 2021
Earnings Per Share [Abstract]
Per Share Data	14 Per Share Data Reconciliations of basic and diluted weighted-average shares of common stock outstanding were as follows: Three Months Ended (Shares in thousands) January 29, 2021 January 31, 2020 Basic Weighted-average number of shares of common stock 108,103 107,380 Assumed issuance of contingent shares 19 43 Weighted-average number of shares of common stock outstanding - Basic 108,122 107,423 Diluted Weighted-average number of shares of common stock outstanding - Basic 108,122 107,423 Effect of dilutive securities 1,072 1,232 Weighted-average number of shares of common stock outstanding - Diluted 109,194 108,655

Contingencies

Contingencies	3 Months Ended
	Jan. 29, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	15 Contingencies Litigation The company is party to litigation in the ordinary course of business. Such matters are generally subject to uncertainties and to outcomes that are not predictable with assurance and that may not be known for extended periods of time. Litigation occasionally involves claims for punitive, as well as compensatory, damages arising out of the use of the company’s products. Although the company is self-insured to some extent, the company maintains insurance against certain product liability losses. The company is also subject to litigation and administrative and judicial proceedings with respect to claims involving asbestos and the discharge of hazardous substances into the environment. Some of these claims assert damages and liability for personal injury, remedial investigations or clean up and other costs and damages. The company is also typically involved in commercial disputes, employment disputes, and patent litigation cases in which it is asserting or defending against patent infringement claims. To prevent possible infringement of the company’s patents by others, the company periodically reviews competitors’ products. To avoid potential liability with respect to others’ patents, the company reviews certain patents issued by the U.S. Patent and Trademark Office and foreign patent offices. The company believes these activities help minimize its risk of being a defendant in patent infringement litigation. The company is currently involved in patent litigation cases, including cases by or against competitors, where it is asserting and defending against claims of patent infringement. Such cases are at varying stages in the litigation process. The company records a liability in its Condensed Consolidated Financial Statements for costs related to claims, including future legal costs, settlements, and judgments, where the company has assessed that a loss is probable and an amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. The company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. In the opinion of management, the amount of liability, if any, with respect to these matters, individually or in the aggregate, will not materially affect its Consolidated Results of Operations, Financial Position, or Cash Flows. In situations where the company receives, or expects to receive, a favorable ruling related to a litigation settlement, the company follows the accounting standards codification guidance for gain contingencies. The company does not allow for the recognition of a gain contingency within its Condensed Consolidated Financial Statements prior to the settlement of the underlying events or contingencies associated with the gain contingency. As a result, the consideration related to a gain contingency is recorded in the Condensed Consolidated Financial Statements during the period in which all underlying events or contingencies are resolved and the gain is realized. Litigation Settlement On November 19, 2020, Exmark Manufacturing Company Incorporated ("Exmark"), a wholly-owned subsidiary of the company, and Briggs & Stratton Corporation (“BGG”) entered into a settlement agreement (“Settlement Agreement”) relating to the decade-long patent infringement litigation that Exmark originally filed in May 2010 against Briggs & Stratton Power Products Group, LLC (“BSPPG”), a former wholly-owned subsidiary of BGG (Case No. 8:10CV187, U.S. District Court for the District of Nebraska) (the “Infringement Action”). In the Infringement Action, Exmark alleged that certain mower decks manufactured by BSPPG infringed an Exmark mower deck patent. Despite favorable judgments in the Infringement Action in favor of Exmark, including with regard to awarded damages, actions by BGG during the second half of calendar 2020 put in jeopardy the certainty and timing of the eventual receipt of the damages awarded to Exmark in the Infringement Action, including (i) the filing by BGG and certain of its subsidiaries for bankruptcy relief under chapter 11 of title 11 of the United States Bankruptcy Code (“BGG Bankruptcy”); (ii) the sale of substantially all the assets (but not certain liabilities, including the Infringement Action) of BGG and its subsidiaries to a third-party pursuant to Section 363 of the United States Bankruptcy Code; and (iii) a petition filed by BGG for a panel rehearing of the United States Court of Appeals for the Federal Circuit's decision in the Infringement Action (“Rehearing Petition”). As a result, on November 19, 2020, Exmark entered into the Settlement Agreement with BGG which provided, among other things, that (i) upon approval by the bankruptcy court, and such approval becoming final and nonappealable, BGG agreed to pay Exmark $33.65 million (“Settlement Amount”), (ii) BGG agreed to immediately withdraw the Rehearing Petition and otherwise not pursue additional appellate review regarding the Infringement Action, and (iii) after receipt of the Settlement Amount, Exmark agreed to release a supersedeas appeal bond that had been obtained by BGG to support payment of the damages award to Exmark in the Infringement Action. On November 20, 2020, BGG filed a motion to withdraw the Rehearing Petition and on December 16, 2020, the bankruptcy court approved the Settlement Agreement. During January 2021, the Settlement Amount was received by Exmark in connection with the settlement of the Infringement Action and at such time, the underlying events and contingencies associated with the gain contingency related to the Infringement Action were satisfied. As such, the company recognized in selling, general and administrative expense within the Condensed Consolidated Statements of Earnings during the first quarter of fiscal 2021 (i) the gain associated with the Infringement Action and (ii) a corresponding expense related to the contingent fee arrangement with the company's external legal counsel customary in patent infringement cases equal to approximately 50 percent of the Settlement Amount.

Leases

Leases	3 Months Ended
	Jan. 29, 2021
Leases [Abstract]
Leases	16 Leases The company enters into contracts that are, or contain, operating lease agreements for certain property, plant, or equipment assets utilized in the normal course of business, such as buildings for manufacturing facilities, office space, distribution centers, and warehouse facilities; land for product testing sites; machinery and equipment for research and development activities, manufacturing and assembly processes, and administrative tasks; and vehicles for sales, service, marketing, and distribution activities. Contracts that explicitly or implicitly relate to property, plant, and equipment are assessed at inception to determine if the contract is, or contains, a lease. Such contracts for operating lease agreements convey the company's right to direct the use of, and obtain substantially all of the economic benefits from, an identified asset for a defined period of time in exchange for consideration. The lease term begins and is determined upon lease commencement, which is the point in time when the company takes possession of the identified asset, and generally includes all non-cancelable periods. Lease expense for the company's operating leases is recognized on a straight-line basis over the lease term and is recorded within cost of sales or selling, general and administrative expense within the Condensed Consolidated Statements of Earnings as dictated by the nature and use of the underlying asset. The company does not recognize right-of-use assets and lease liabilities, but does recognize expense on a straight-line basis, for short-term operating leases which have a lease term of 12 months or less and do not include an option to purchase the underlying asset. Lease payments are determined at lease commencement and generally represent fixed lease payments as defined within the respective lease agreement or, in the case of certain lease agreements, variable lease payments that are measured as of the lease commencement date based on the prevailing index or market rate. Future adjustments to variable lease payments are defined and scheduled within the respective lease agreement and are determined based upon the prevailing market or index rate at the time of the adjustment relative to the market or index rate determined at lease commencement. Certain other lease agreements contain variable lease payments that are determined based upon actual utilization of the identified asset. Such future adjustments to variable lease payments and variable lease payments based upon actual utilization of the identified asset are not included within the determination of lease payments at commencement but rather, are recorded as variable lease expense in the period in which the variable lease cost is incurred. Right-of-use assets represent the company's right to use an underlying asset throughout the lease term and lease liabilities represent the company's obligation to make lease payments arising from the lease agreement. The company accounts for operating lease liabilities at lease commencement and on an ongoing basis as the present value of the minimum remaining lease payments under the respective lease term. Minimum remaining lease payments are generally discounted to present value based the estimated incremental borrowing rate at lease commencement as the rate implicit in the lease is generally not readily determinable. Right-of-use assets are measured as the amount of the corresponding operating lease liability for the respective operating lease agreement, adjusted for prepaid or accrued lease payments, the remaining balance of any lease incentives received, unamortized initial direct costs, and impairment of the operating lease right-of-use asset, as applicable. The following table presents the lease expense incurred on the company’s operating, short-term, and variable leases: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Operating lease expense $ 4,974 $ 4,834 Short-term lease expense 580 682 Variable lease expense 17 37 Total lease expense $ 5,571 $ 5,553 The following table presents supplemental cash flow information related to the company's operating leases: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Operating cash flows for amounts included in the measurement of lease liabilities $ 4,682 $ 4,741 Right-of-use assets obtained in exchange for lease obligations $ 293 $ 6,133 The following table presents other lease information related to the company's operating leases: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Weighted-average remaining lease term of operating leases in years 6.9 6.2 7.1 Weighted-average discount rate of operating leases 2.78 % 2.81 % 2.79 % The following table reconciles the total undiscounted future cash flows based on the anticipated future minimum operating lease payments by fiscal year for the company's operating leases to the present value of operating lease liabilities recorded within the Condensed Consolidated Balance Sheets as of January 29, 2021: (Dollars in thousands) January 29, 2021 2021 (remaining) $ 18,801 2022 15,910 2023 12,515 2024 11,044 2025 9,987 Thereafter 23,613 Total future minimum operating lease payments 91,870 Less: imputed interest 13,033 Present value of operating lease liabilities $ 78,837

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	3 Months Ended
	Jan. 29, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	17 Derivative Instruments and Hedging Activities Risk Management Objective of Using Derivatives The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third-party customers, sales and loans to wholly-owned foreign subsidiaries, costs associated with foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro. To reduce its exposure to foreign currency exchange rate risk, the company actively manages the exposure of its foreign currency exchange rate risk by entering into various derivative instruments to hedge against such risk, authorized under a company policy that places controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty. The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency. The company recognizes all derivative instruments at fair value on the Condensed Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument. Cash Flow Hedging Instruments The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third-parties and costs associated with foreign plant operations, including purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods. Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Condensed Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Condensed Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Condensed Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and costs associated with foreign plant operations, including purchases from suppliers, are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Condensed Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Condensed Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Condensed Consolidated Statements of Earnings. As of January 29, 2021, the notional amount outstanding of forward currency contracts designated as cash flow hedging instruments was $259.9 million. Derivatives Not Designated as Cash Flow Hedging Instruments The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Condensed Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Condensed Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position. The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Derivative assets: Derivatives designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts $ 1,294 $ 9,244 $ 802 Derivatives not designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts 178 3,432 131 Total assets $ 1,472 $ 12,676 $ 933 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts $ 14,763 $ — $ 2,687 Derivatives not designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts 2,200 — (203) Total liabilities $ 16,963 $ — $ 2,484 The company entered into an International Swap Dealers Association ("ISDA") Master Agreement with each counterparty that permits the net settlement of amounts owed under their respective contracts. The ISDA Master Agreement is an industry standardized contract that governs all derivative contracts entered into between the company and the respective counterparty. Under these master netting agreements, net settlement generally permits the company or the counterparty to determine the net amount payable or receivable for contracts due on the same date or in the same currency for similar types of derivative transactions. The company records the fair value of its derivative instruments at the net amount on its Condensed Consolidated Balance Sheets. The following table presents the effects of the master netting arrangements on the fair value of the company’s derivative instruments that are recorded on the Condensed Consolidated Balance Sheets: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Derivative assets: Forward currency contracts: Gross amounts of recognized assets $ 1,472 $ 12,841 $ 1,139 Gross liabilities offset in the Condensed Consolidated Balance Sheets — (165) (206) Net amounts of assets presented in the Condensed Consolidated Balance Sheets $ 1,472 $ 12,676 $ 933 Derivative liabilities: Forward currency contracts: Gross amounts of recognized liabilities $ (16,970) $ — $ (3,233) Gross assets offset in the Condensed Consolidated Balance Sheets 7 — 749 Net amounts of liabilities presented in the Condensed Consolidated Balance Sheets $ (16,963) $ — $ (2,484) The following tables present the impact and location of the amounts reclassified from AOCL into net earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three months ended January 29, 2021 and January 31, 2020: Three Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain (Loss) Recognized in OCI on Derivatives (Dollars in thousands) January 29, 2021 January 31, 2020 January 29, 2021 January 31, 2020 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ (2,097) $ 1,205 $ (7,694) $ 584 Cost of sales 99 332 (616) 68 Total derivatives designated as cash flow hedging instruments $ (1,998) $ 1,537 $ (8,310) $ 652 The company recognized immaterial gains within other income, net on the Condensed Consolidated Statements of Earnings during the first quarter of fiscal 2021 and fiscal 2020 due to the discontinuance of cash flow hedge accounting on certain forward currency contracts designated as cash flow hedging instruments. As of January 29, 2021, the company expects to reclassify approximately $11.6 million of losses from AOCL to earnings during the next twelve months. The following tables present the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing: Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) January 29, 2021 January 31, 2020 Three Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 872,986 $ (557,950) $ 767,483 $ (479,395) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings (2,097) 99 1,205 332 Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 162 $ 185 $ 660 $ 11 The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Gain (loss) on derivatives not designated as cash flow hedging instruments Forward currency contracts: Other income, net $ (3,478) $ 220 Total gain (loss) on derivatives not designated as cash flow hedging instruments $ (3,478) $ 220

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Jan. 29, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	18 Fair Value Measurements The company categorizes its assets and liabilities into one of three levels based on the assumptions (inputs) used in valuing the asset or liability. Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value, and requires certain disclosures. The framework discusses valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flows), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 : Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 : Unobservable inputs reflecting management’s assumptions about the inputs used in pricing the asset or liability. Recurring Fair Value Measurements The company's derivative instruments consist of forward currency contracts that are measured at fair value on a recurring basis. The fair value of such forward currency contracts is determined based on observable market transactions of forward currency prices and spot currency rates as of the reporting date. The following tables present, by level within the fair value hierarchy, the company's financial assets and liabilities that are measured at fair value on a recurring basis as of January 29, 2021, January 31, 2020, and October 31, 2020, according to the valuation technique utilized to determine their fair values: (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: January 29, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 1,472 $ — $ 1,472 $ — Total assets $ 1,472 $ — $ 1,472 $ — Liabilities: Forward currency contracts $ 16,963 $ — $ 16,963 $ — Total liabilities $ 16,963 $ — $ 16,963 $ — (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: January 31, 2020 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 12,676 $ — $ 12,676 $ — Total assets $ 12,676 $ — $ 12,676 $ — (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: October 31, 2020 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 933 $ — $ 933 $ — Total assets $ 933 $ — $ 933 $ — Liabilities: Forward currency contracts $ 2,484 $ — $ 2,484 $ — Total liabilities $ 2,484 $ — $ 2,484 $ — Nonrecurring Fair Value Measurements The company measures certain assets and liabilities at fair value on a non-recurring basis. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, goodwill, and indefinite-lived intangible assets, which would generally be recorded at fair value as a result of an impairment charge. Assets acquired and liabilities assumed as part of a business combination or asset acquisition are also measured at fair value on a non-recurring basis during the measurement period allowed by the accounting standards codification guidance for business combinations, when applicable. For additional information on the company's business combination and the related non-recurring fair value measurement of the assets acquired and liabilities assumed, refer to Note 2, Business Combination . Other Fair Value Disclosures The carrying values of the company's short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and short-term debt, including current maturities of long-term debt, when applicable, approximate their fair values due to their short-term nature. As of January 29, 2021, January 31, 2020 and October 31, 2020, the company's long-term debt included $424.0 million, $423.9 million and $424.0 million, respectively, of gross fixed-rate debt that is not subject to variable interest rate fluctuations. The gross fair value of such long-term debt is determined using Level 2 inputs by discounting the projected cash flows based on quoted market rates at which similar amounts of debt could currently be borrowed. As of January 29, 2021, the estimated gross fair value of long-term debt with fixed interest rates was $524.3 million compared to its gross carrying amount of $424.0 million. As of January 31, 2020, the estimated gross fair value of long-term debt with fixed interest rates was $513.7 million compared to its gross carrying amount of $423.9 million. As of October 31, 2020, the estimated gross fair value of long-term debt with fixed interest rates was $508.2 million compared to its gross carrying amount of $424.0 million.

Subsequent Events

Subsequent Events	3 Months Ended
	Jan. 29, 2021
Subsequent Events [Abstract]
Subsequent Events	19 Subsequent Events The company has evaluated all subsequent events and concluded that no subsequent events have occurred that would require recognition in the Condensed Consolidated Financial Statements or disclosure in the Notes to the Condensed Consolidated Financial Statements.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Jan. 29, 2021
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States ("U.S.") generally accepted accounting principles ("GAAP") for complete financial statements. Unless the context indicates otherwise, the terms "company," "TTC," "we," "our," or "us" refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements.In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's Consolidated Financial Position, Results of Operations, and Cash Flows for the periods presented.
Fiscal Period	The company’s fiscal year ends on October 31, and quarterly results are reported based on three-month periods that generally end on the Friday closest to the calendar quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end.
Accounting Policies and Estimates	In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty accruals, allowances for current expected credit losses, pension accruals, self-insurance accruals, legal accruals, right-of-use assets and lease liabilities, useful lives for tangible and finite-lived intangible assets, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, and valuations of the assets acquired and liabilities assumed in a business combination, when applicable. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made and are generally derived from management's understanding and analysis of the relevant and current circumstances, historical experience, and actuarial and other independent external third-party specialist valuations, when applicable. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the economic environment. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, including those impacted by the COVID-19 pandemic, actual amounts could differ significantly from those estimated at the time the Condensed Consolidated Financial Statements are prepared.
New Accounting Pronouncements Adopted and New Accounting Pronouncements Not Yet Adopted	1 Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States ("U.S.") generally accepted accounting principles ("GAAP") for complete financial statements. Unless the context indicates otherwise, the terms "company," "TTC," "we," "our," or "us" refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements. In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's Consolidated Financial Position, Results of Operations, and Cash Flows for the periods presented. Due to seasonality within the industries in which the company's business operates and the current COVID-19 pandemic, among other factors, operating results for the three months ended January 29, 2021 cannot be annualized to determine the expected results for the fiscal year ending October 31, 2021. The company’s fiscal year ends on October 31, and quarterly results are reported based on three-month periods that generally end on the Friday closest to the calendar quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end. For further information regarding the company's basis of presentation, refer to the Consolidated Financial Statements and Notes to Consolidated Financial Statements included in the company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2020. The policies described in that report are used for preparing the company's quarterly reports on Form 10-Q. Impact of COVID-19 Pandemic In March 2020, the World Health Organization declared the novel coronavirus ("COVID-19" or "the pandemic") outbreak a global pandemic. COVID-19 has negatively impacted public health and portions of the global economy, disrupted global supply chains, and created volatility in financial markets. The continuing implications of COVID-19 on the company remain uncertain and will depend on certain future developments, including the duration, scope, and severity of the pandemic; its impact on the company's employees, customers, and suppliers; the range of government mandated restrictions and other measures; and the success of the deployment of approved COVID-19 vaccines and their effectiveness. This uncertainty could have a material impact on accounting estimates and assumptions utilized to prepare the Condensed Consolidated Financial Statements in future reporting periods, which could result in a material adverse impact on the company's Consolidated Financial Position, Results of Operations, and Cash Flows. Accounting Policies and Estimates In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty accruals, allowances for current expected credit losses, pension accruals, self-insurance accruals, legal accruals, right-of-use assets and lease liabilities, useful lives for tangible and finite-lived intangible assets, future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, and valuations of the assets acquired and liabilities assumed in a business combination, when applicable. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made and are generally derived from management's understanding and analysis of the relevant and current circumstances, historical experience, and actuarial and other independent external third-party specialist valuations, when applicable. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the economic environment. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, including those impacted by the COVID-19 pandemic, actual amounts could differ significantly from those estimated at the time the Condensed Consolidated Financial Statements are prepared. New Accounting Pronouncements Adopted In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which modifies the measurement approach for credit losses on financial assets measured on an amortized cost basis from an 'incurred loss' method to an 'expected loss' method. Such modification of the measurement approach for credit losses eliminates the requirement that a credit loss be considered probable, or incurred, to impact the valuation of a financial asset measured on an amortized cost basis. The amended guidance requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions, and a reasonable and supportable forecast that affects the collectability of the related financial asset. This amendment affects trade receivables, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope of this amendment that have the contractual right to receive cash. The amended guidance was adopted in the first quarter of fiscal 2021, under the modified retrospective transition method. The adoption of the amended guidance did not have a material impact on the company's Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) - Changes to the Disclosure Requirements for Fair Value Measurement , which modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The amended guidance was adopted in the first quarter of fiscal 2021 and did not have a material impact on the company's Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans (Topic 715) , which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. The amended guidance was adopted in the first quarter of fiscal 2021 and did not have a material impact on the company's Condensed Consolidated Financial Statements. New Accounting Pronouncements Not Yet Adopted In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The amended guidance also clarifies and simplifies other aspects of the accounting for income taxes under accounting standards codification Topic 740, Income Taxes . The amended guidance will become effective in the first quarter of fiscal 2022. Early adoption is permitted. The company is currently evaluating the impact of this new standard on its Condensed Consolidated Financial Statements. In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarified that before applying or upon discontinuing the equity method of accounting for an investment in equity securities, an entity should consider observable transactions that require it to apply or discontinue the equity method of accounting for the purposes of applying the fair value measurement alternative. The amended guidance will become effective in the first quarter of fiscal 2022. Early adoption is permitted. The company is currently evaluating the impact of this standard on its Condensed Consolidated Financial Statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides temporary optional guidance to ease the potential burden of accounting for reference rate reform due to the cessation of the London Interbank Offered Rate, commonly referred to as "LIBOR." The temporary guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, relationships, and transactions affected by reference rate reform if certain criteria are met. The provisions of the temporary optional guidance are only available until December 31, 2022, when the reference rate reform activity is expected to be substantially complete. When adopted, entities may apply the provisions as of the beginning of the reporting period when the election is made. The company is currently evaluating the impact of this standard on its Condensed Consolidated Financial Statements and has yet to elect an adoption date. The company believes that all other recently issued accounting pronouncements from the FASB that the company has not noted above, will not have a material impact on its Condensed Consolidated Financial Statements or do not apply to its operations.
Derivative Instruments and Hedging Activities	Risk Management Objective of Using Derivatives The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third-party customers, sales and loans to wholly-owned foreign subsidiaries, costs associated with foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro. To reduce its exposure to foreign currency exchange rate risk, the company actively manages the exposure of its foreign currency exchange rate risk by entering into various derivative instruments to hedge against such risk, authorized under a company policy that places controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty. The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency. The company recognizes all derivative instruments at fair value on the Condensed Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument. Cash Flow Hedging Instruments The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third-parties and costs associated with foreign plant operations, including purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods. Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Condensed Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Condensed Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Condensed Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and costs associated with foreign plant operations, including purchases from suppliers, are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Condensed Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Condensed Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Condensed Consolidated Statements of Earnings. As of January 29, 2021, the notional amount outstanding of forward currency contracts designated as cash flow hedging instruments was $259.9 million. Derivatives Not Designated as Cash Flow Hedging Instruments The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Condensed Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Condensed Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position.
Fair Value Measurements	Recurring Fair Value MeasurementsThe company's derivative instruments consist of forward currency contracts that are measured at fair value on a recurring basis. The fair value of such forward currency contracts is determined based on observable market transactions of forward currency prices and spot currency rates as of the reporting date. Nonrecurring Fair Value Measurements The company measures certain assets and liabilities at fair value on a non-recurring basis. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, goodwill, and indefinite-lived intangible assets, which would generally be recorded at fair value as a result of an impairment charge. Assets acquired and liabilities assumed as part of a business combination or asset acquisition are also measured at fair value on a non-recurring basis during the measurement period allowed by the accounting standards codification guidance for business combinations, when applicable. For additional information on the company's business combination and the related non-recurring fair value measurement of the assets acquired and liabilities assumed, refer to Note 2, Business Combination . Other Fair Value Disclosures

Business Combination (Tables)

Business Combination (Tables)	3 Months Ended
	Jan. 29, 2021
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the allocation of the purchase price to the fair values assigned to the Venture Products assets acquired and liabilities assumed: (Dollars in thousands) March 2, 2020 Cash and cash equivalents $ 3,476 Receivables 6,342 Inventories 23,000 Prepaid expenses and other current assets 239 Property, plant and equipment 26,976 Goodwill 61,225 Other intangible assets: Finite-lived customer-related 19,100 Indefinite-lived trade name 56,200 Accounts payable (4,075) Accrued liabilities (5,196) Deferred income tax liabilities (20,586) Total fair value of net assets acquired 166,701 Less: cash and cash equivalents acquired (3,476) Total purchase price $ 163,225

Segment Data (Tables)

Segment Data (Tables)	3 Months Ended
	Jan. 29, 2021
Segment Reporting [Abstract]
Summarized Financial Information Concerning Reportable Segments	The following tables present summarized financial information concerning the company’s reportable segments and Other activities: (Dollars in thousands) Three Months Ended January 29, 2021 Professional Residential Other Total Net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Intersegment gross sales (eliminations) 6,642 16 (6,658) — Earnings (loss) before income taxes 116,816 32,108 (13,098) 135,826 Total assets $ 1,952,536 $ 345,185 $ 577,417 $ 2,875,138 (Dollars in thousands) Three Months Ended January 31, 2020 Professional Residential Other Total Net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483 Intersegment gross sales (eliminations) 8,771 27 (8,798) — Earnings (loss) before income taxes 102,474 21,566 (37,901) 86,139 Total assets $ 1,853,739 $ 324,089 $ 313,781 $ 2,491,609
Summary of Components of Loss Before Income Taxes Included in Other Segment	The following table presents the details of operating loss before income taxes for the company's Other activities: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Corporate expenses $ (11,303) $ (32,442) Interest expense (7,522) (8,156) Earnings from wholly-owned domestic distribution companies and other income, net 5,727 2,697 Total operating loss $ (13,098) $ (37,901)

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Jan. 29, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following tables disaggregate the company's reportable segment net sales by major product type and geographic market (in thousands): Three Months Ended January 29, 2021 Professional Residential Other Total Revenue by product type: Equipment $ 575,775 $ 205,923 $ 3,942 $ 785,640 Irrigation 74,448 11,777 1,121 87,346 Total net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Revenue by geographic market: United States $ 501,860 $ 174,382 $ 5,063 $ 681,305 International Countries 148,363 43,318 — 191,681 Total net sales $ 650,223 $ 217,700 $ 5,063 $ 872,986 Three Months Ended January 31, 2020 Professional Residential Other Total Revenue by product type: Equipment $ 523,909 $ 152,458 $ 5,525 $ 681,892 Irrigation 70,812 13,390 1,389 85,591 Total net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483 Revenue by geographic market: United States $ 454,396 $ 130,338 $ 6,914 $ 591,648 International Countries 140,325 35,510 — 175,835 Total net sales $ 594,721 $ 165,848 $ 6,914 $ 767,483

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets, Net (Tables)	3 Months Ended
	Jan. 29, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill by reportable segment for the first three months of fiscal 2021 were as follows: (Dollars in thousands) Professional Residential Other Total Balance as of October 31, 2020 $ 412,061 $ 10,480 $ 1,534 $ 424,075 Purchase price allocation adjustment (1,027) — — (1,027) Goodwill divested — — (1,534) (1,534) Translation adjustments 518 131 — 649 Balance as of January 29, 2021 $ 411,552 $ 10,611 $ — $ 422,163
Schedule of Finite-Lived Intangible Assets	The components of other intangible assets, net as of January 29, 2021 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,123) $ 4,152 Non-compete agreements 5.5 6,908 (6,851) 57 Customer-related 18.2 239,816 (51,747) 188,069 Developed technology 7.7 59,017 (36,230) 22,787 Trade names 15.3 7,563 (2,684) 4,879 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.3 335,969 (116,025) 219,944 Indefinite-lived - trade names 190,643 — 190,643 Total other intangible assets, net $ 526,612 $ (116,025) $ 410,587 The components of other intangible assets, net as of January 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,238 $ (13,307) $ 4,931 Non-compete agreements 5.5 6,875 (6,798) 77 Customer-related 18.4 220,364 (36,970) 183,394 Developed technology 7.6 51,902 (32,264) 19,638 Trade names 15.4 7,485 (2,208) 5,277 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 309,254 (95,937) 213,317 Indefinite-lived - trade names 134,326 — 134,326 Total other intangible assets, net $ 443,580 $ (95,937) $ 347,643 The components of other intangible assets, net as of October 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,257 $ (13,919) $ 4,338 Non-compete agreements 5.5 6,892 (6,831) 61 Customer-related 18.2 239,634 (48,005) 191,629 Developed technology 7.6 51,995 (35,208) 16,787 Trade names 15.4 7,530 (2,552) 4,978 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 328,698 (110,905) 217,793 Indefinite-lived - trade names 190,512 — 190,512 Total other intangible assets, net $ 519,210 $ (110,905) $ 408,305
Schedule of Indefinite-Lived Intangible Assets	The components of other intangible assets, net as of January 29, 2021 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,275 $ (14,123) $ 4,152 Non-compete agreements 5.5 6,908 (6,851) 57 Customer-related 18.2 239,816 (51,747) 188,069 Developed technology 7.7 59,017 (36,230) 22,787 Trade names 15.3 7,563 (2,684) 4,879 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.3 335,969 (116,025) 219,944 Indefinite-lived - trade names 190,643 — 190,643 Total other intangible assets, net $ 526,612 $ (116,025) $ 410,587 The components of other intangible assets, net as of January 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,238 $ (13,307) $ 4,931 Non-compete agreements 5.5 6,875 (6,798) 77 Customer-related 18.4 220,364 (36,970) 183,394 Developed technology 7.6 51,902 (32,264) 19,638 Trade names 15.4 7,485 (2,208) 5,277 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 309,254 (95,937) 213,317 Indefinite-lived - trade names 134,326 — 134,326 Total other intangible assets, net $ 443,580 $ (95,937) $ 347,643 The components of other intangible assets, net as of October 31, 2020 were as follows: (Dollars in thousands) Weighted-Average Useful Life in Years Gross Carrying Amount Accumulated Amortization Net Patents 9.9 $ 18,257 $ (13,919) $ 4,338 Non-compete agreements 5.5 6,892 (6,831) 61 Customer-related 18.2 239,634 (48,005) 191,629 Developed technology 7.6 51,995 (35,208) 16,787 Trade names 15.4 7,530 (2,552) 4,978 Backlog and other 0.6 4,390 (4,390) — Total finite-lived 15.5 328,698 (110,905) 217,793 Indefinite-lived - trade names 190,512 — 190,512 Total other intangible assets, net $ 519,210 $ (110,905) $ 408,305

Indebtedness (Tables)

Indebtedness (Tables)	3 Months Ended
	Jan. 29, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following is a summary of the company's indebtedness: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Revolving credit facility $ — $ 14,000 $ — $200 million term loan 100,000 100,000 100,000 $300 million term loan 180,000 180,000 180,000 $190 million term loan — — 90,000 3.81% series A senior notes 100,000 100,000 100,000 3.91% series B senior notes 100,000 100,000 100,000 7.8% debentures 100,000 100,000 100,000 6.625% senior notes 123,993 123,931 123,978 Less: unamortized discounts, debt issuance costs, and deferred charges 2,645 3,012 2,855 Total long-term debt 701,348 714,919 791,123 Less: current portion of long-term debt 9,992 113,903 99,873 Long-term debt, less current portion $ 691,356 $ 601,016 $ 691,250

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Jan. 29, 2021
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories were as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Raw materials and work in process $ 226,979 $ 188,235 $ 168,759 Finished goods and service parts 530,415 632,796 565,761 Total FIFO value 757,394 821,031 734,520 Less: adjustment to LIFO value 82,087 82,071 82,087 Total inventories, net $ 675,307 $ 738,960 $ 652,433

Property and Depreciation (Tabl

Property and Depreciation (Tables)	3 Months Ended
	Jan. 29, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, plant and equipment was as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Land and land improvements $ 56,808 $ 55,602 $ 57,387 Buildings and leasehold improvements 299,566 276,705 301,848 Machinery and equipment 500,410 450,321 499,312 Tooling 231,728 216,541 231,142 Computer hardware and software 102,357 94,385 102,312 Construction in process 58,346 58,056 48,157 Property, plant, and equipment, gross 1,249,215 1,151,610 1,240,158 Less: accumulated depreciation 792,068 720,357 772,239 Property, plant, and equipment, net $ 457,147 $ 431,253 $ 467,919

Warranty Guarantees (Tables)

Warranty Guarantees (Tables)	3 Months Ended
	Jan. 29, 2021
Product Warranties Disclosures [Abstract]
Schedule of Warranty Provisions, Claims, and Changes in Estimates	The changes in accrued warranties were as follows: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Beginning balance $ 107,121 $ 96,604 Provisions 16,695 14,031 Claims (15,186) (14,703) Changes in estimates 153 691 Ending balance $ 108,783 $ 96,623

Stock-Based Compensation Plans

Stock-Based Compensation Plans (Tables)	3 Months Ended
	Jan. 29, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Compensation Cost Related to Stock-Based Awards	Compensation costs related to stock-based compensation awards were as follows: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Stock option awards $ 2,058 $ 1,777 Performance share awards 827 548 Restricted stock unit awards 960 942 Unrestricted common stock awards 671 693 Total compensation cost for stock-based compensation awards $ 4,516 $ 3,960
Schedule of Assumptions for Options Granted	The table below illustrates the weighted-average valuation assumptions for options granted in the first three months of the following fiscal periods: Fiscal 2021 Fiscal 2020 Expected life of option in years 6.21 6.31 Expected stock price volatility 23.26% 19.38% Risk-free interest rate 0.55% 1.79% Expected dividend yield 0.86% 0.98% Per share weighted-average fair value at date of grant $19.38 $15.37

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Jan. 29, 2021
Stockholders' Equity Note [Abstract]
Schedule of Components of Accumulated Other Comprehensive Loss (AOCL), Net of Tax	The components of accumulated other comprehensive loss ("AOCL"), net of tax, within the Condensed Consolidated Statements of Stockholders' Equity were as follows: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Foreign currency translation adjustments $ 14,112 $ 31,749 $ 24,508 Pension benefits 5,106 4,861 5,106 Cash flow derivative instruments 12,958 (4,489) 4,648 Total accumulated other comprehensive loss $ 32,176 $ 32,121 $ 34,262
Schedule of Components and Activity of AOCL	The components and activity of AOCL, net of tax, for the three months of fiscal 2021 and 2020 were as follows: (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2020 $ 24,508 $ 5,106 $ 4,648 $ 34,262 Other comprehensive (income) loss before reclassifications (10,396) — 6,312 (4,084) Amounts reclassified from AOCL — — 1,998 1,998 Net current period other comprehensive (income) loss (10,396) — 8,310 (2,086) Balance as of January 29, 2021 $ 14,112 $ 5,106 $ 12,958 $ 32,176 (Dollars in thousands) Foreign Pension Cash Flow Derivative Instruments Total Balance as of October 31, 2019 $ 31,025 $ 4,861 $ (3,837) $ 32,049 Other comprehensive loss before reclassifications 724 — 885 1,609 Amounts reclassified from AOCL — — (1,537) (1,537) Net current period other comprehensive (income) loss 724 — (652) 72 Balance as of January 31, 2020 $ 31,749 $ 4,861 $ (4,489) $ 32,121

Per Share Data (Tables)

Per Share Data (Tables)	3 Months Ended
	Jan. 29, 2021
Earnings Per Share [Abstract]
Reconciliations of basic and diluted weighted-average shares of common stock outstanding	Reconciliations of basic and diluted weighted-average shares of common stock outstanding were as follows: Three Months Ended (Shares in thousands) January 29, 2021 January 31, 2020 Basic Weighted-average number of shares of common stock 108,103 107,380 Assumed issuance of contingent shares 19 43 Weighted-average number of shares of common stock outstanding - Basic 108,122 107,423 Diluted Weighted-average number of shares of common stock outstanding - Basic 108,122 107,423 Effect of dilutive securities 1,072 1,232 Weighted-average number of shares of common stock outstanding - Diluted 109,194 108,655

Leases (Tables)

Leases (Tables)	3 Months Ended
	Jan. 29, 2021
Leases [Abstract]
Supplemental Cash Flow and Other Lease Information	The following table presents the lease expense incurred on the company’s operating, short-term, and variable leases: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Operating lease expense $ 4,974 $ 4,834 Short-term lease expense 580 682 Variable lease expense 17 37 Total lease expense $ 5,571 $ 5,553 The following table presents supplemental cash flow information related to the company's operating leases: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Operating cash flows for amounts included in the measurement of lease liabilities $ 4,682 $ 4,741 Right-of-use assets obtained in exchange for lease obligations $ 293 $ 6,133 The following table presents other lease information related to the company's operating leases: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Weighted-average remaining lease term of operating leases in years 6.9 6.2 7.1 Weighted-average discount rate of operating leases 2.78 % 2.81 % 2.79 %
Future Minimum Operating Lease Payments	The following table reconciles the total undiscounted future cash flows based on the anticipated future minimum operating lease payments by fiscal year for the company's operating leases to the present value of operating lease liabilities recorded within the Condensed Consolidated Balance Sheets as of January 29, 2021: (Dollars in thousands) January 29, 2021 2021 (remaining) $ 18,801 2022 15,910 2023 12,515 2024 11,044 2025 9,987 Thereafter 23,613 Total future minimum operating lease payments 91,870 Less: imputed interest 13,033 Present value of operating lease liabilities $ 78,837

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	3 Months Ended
	Jan. 29, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Derivatives and Consolidated Balance Sheet Location	The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Derivative assets: Derivatives designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts $ 1,294 $ 9,244 $ 802 Derivatives not designated as cash flow hedging instruments: Prepaid expenses and other current assets Forward currency contracts 178 3,432 131 Total assets $ 1,472 $ 12,676 $ 933 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts $ 14,763 $ — $ 2,687 Derivatives not designated as cash flow hedging instruments: Accrued liabilities Forward currency contracts 2,200 — (203) Total liabilities $ 16,963 $ — $ 2,484
Schedule of Effects of Master Netting Arrangements on Fair Value of Derivative Contracts Recorded in Consolidated Balance Sheets	The following table presents the effects of the master netting arrangements on the fair value of the company’s derivative instruments that are recorded on the Condensed Consolidated Balance Sheets: (Dollars in thousands) January 29, 2021 January 31, 2020 October 31, 2020 Derivative assets: Forward currency contracts: Gross amounts of recognized assets $ 1,472 $ 12,841 $ 1,139 Gross liabilities offset in the Condensed Consolidated Balance Sheets — (165) (206) Net amounts of assets presented in the Condensed Consolidated Balance Sheets $ 1,472 $ 12,676 $ 933 Derivative liabilities: Forward currency contracts: Gross amounts of recognized liabilities $ (16,970) $ — $ (3,233) Gross assets offset in the Condensed Consolidated Balance Sheets 7 — 749 Net amounts of liabilities presented in the Condensed Consolidated Balance Sheets $ (16,963) $ — $ (2,484)
Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Designated as Cash Flow Hedging Instruments	The following tables present the impact and location of the amounts reclassified from AOCL into net earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three months ended January 29, 2021 and January 31, 2020: Three Months Ended Gain (Loss) Reclassified from AOCL into Earnings Gain (Loss) Recognized in OCI on Derivatives (Dollars in thousands) January 29, 2021 January 31, 2020 January 29, 2021 January 31, 2020 Derivatives designated as cash flow hedging instruments: Forward currency contracts: Net sales $ (2,097) $ 1,205 $ (7,694) $ 584 Cost of sales 99 332 (616) 68 Total derivatives designated as cash flow hedging instruments $ (1,998) $ 1,537 $ (8,310) $ 652 The following tables present the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing: Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments (Dollars in thousands) January 29, 2021 January 31, 2020 Three Months Ended Net Sales Cost of Sales Net Sales Cost of Sales Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded $ 872,986 $ (557,950) $ 767,483 $ (479,395) Gain (loss) on derivatives designated as cash flow hedging instruments: Forward currency contracts: Amount of gain (loss) reclassified from AOCL into earnings (2,097) 99 1,205 332 Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 162 $ 185 $ 660 $ 11
Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Not Designated as Hedging Instruments	The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments: Three Months Ended (Dollars in thousands) January 29, 2021 January 31, 2020 Gain (loss) on derivatives not designated as cash flow hedging instruments Forward currency contracts: Other income, net $ (3,478) $ 220 Total gain (loss) on derivatives not designated as cash flow hedging instruments $ (3,478) $ 220

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Jan. 29, 2021
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present, by level within the fair value hierarchy, the company's financial assets and liabilities that are measured at fair value on a recurring basis as of January 29, 2021, January 31, 2020, and October 31, 2020, according to the valuation technique utilized to determine their fair values: (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: January 29, 2021 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 1,472 $ — $ 1,472 $ — Total assets $ 1,472 $ — $ 1,472 $ — Liabilities: Forward currency contracts $ 16,963 $ — $ 16,963 $ — Total liabilities $ 16,963 $ — $ 16,963 $ — (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: January 31, 2020 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 12,676 $ — $ 12,676 $ — Total assets $ 12,676 $ — $ 12,676 $ — (Dollars in thousands) Fair Value Measurements Using Inputs Considered as: October 31, 2020 Fair Value Level 1 Level 2 Level 3 Assets: Forward currency contracts $ 933 $ — $ 933 $ — Total assets $ 933 $ — $ 933 $ — Liabilities: Forward currency contracts $ 2,484 $ — $ 2,484 $ — Total liabilities $ 2,484 $ — $ 2,484 $ —

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Thousands	Mar. 02, 2020	Oct. 31, 2021	Jan. 29, 2021	Jul. 31, 2020	Jan. 31, 2020	Jan. 29, 2021	Oct. 31, 2020
Business Acquisition [Line Items]
Business combination, consideration transferred, holdback expired				$ 4,500
Purchase price allocation adjustment			$ (1,027)
Finite-lived intangible asset, useful life			15 years 3 months 18 days		15 years 6 months		15 years 6 months
Scenario, Forecast
Business Acquisition [Line Items]
Business combination, consideration transferred, holdback		$ 25,000
Venture Products, Inc Affiliate
Business Acquisition [Line Items]
Payments to acquire businesses, gross	$ 136,400
Business combination, consideration transferred, holdback	29,500
Total purchase price	163,225			$ 163,200
Purchase price allocation adjustment			$ (1,000)
Other intangible assets	75,300
Finite-lived intangible asset, useful life						16 years
Previously Reported | Venture Products, Inc Affiliate
Business Acquisition [Line Items]
Preliminary purchase price	$ 165,900

Business Combination - Allocati

Business Combination - Allocation of Preliminary Purchase Price, Venture Products (Details) - USD ($) $ in Thousands	Mar. 02, 2020	Jul. 31, 2020	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Business Acquisition [Line Items]
Goodwill			$ 422,163	$ 424,075	$ 362,136
Venture Products, Inc Affiliate
Business Acquisition [Line Items]
Cash and cash equivalents	$ 3,476
Receivables	6,342
Inventories	23,000
Prepaid expenses and other current assets	239
Property, plant and equipment	26,976
Goodwill	61,225
Finite-lived customer-related	19,100
Indefinite-lived trade name	56,200
Accounts payable	(4,075)
Accrued liabilities	(5,196)
Deferred income tax liabilities	(20,586)
Total fair value of net assets acquired	166,701
Less: cash and cash equivalents acquired	(3,476)
Total purchase price	$ 163,225	$ 163,200

Segment Data - Narrative (Detai

Segment Data - Narrative (Details)	3 Months Ended
	Jan. 29, 2021segment
Segment Reporting [Abstract]
Number of operating segments	11
Number of reportable segments	2

Segment Data - Summarized Finan

Segment Data - Summarized Financial Information of Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020	Oct. 31, 2020
Financial information concerning reportable segments
Net sales	$ 872,986	$ 767,483
Earnings (loss) before income taxes	135,826	86,139
Total assets	2,875,138	2,491,609	$ 2,853,228
Operating Segments | Professional
Financial information concerning reportable segments
Net sales	650,223	594,721
Earnings (loss) before income taxes	116,816	102,474
Total assets	1,952,536	1,853,739
Operating Segments | Residential
Financial information concerning reportable segments
Net sales	217,700	165,848
Earnings (loss) before income taxes	32,108	21,566
Total assets	345,185	324,089
Intersegment gross sales (eliminations)
Financial information concerning reportable segments
Net sales	(6,658)	(8,798)
Intersegment gross sales (eliminations) | Professional
Financial information concerning reportable segments
Net sales	6,642	8,771
Intersegment gross sales (eliminations) | Residential
Financial information concerning reportable segments
Net sales	16	27
Other
Financial information concerning reportable segments
Net sales	5,063	6,914
Earnings (loss) before income taxes	(13,098)	(37,901)
Total assets	$ 577,417	$ 313,781

Segment Data - Components of Lo

Segment Data - Components of Loss before Income Taxes Included in Other (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Components of the loss before income taxes included in "Other"
Interest expense	$ (7,522)	$ (8,156)
Earnings from wholly-owned domestic distribution companies and other income, net	1,883	3,166
Earnings before income taxes	135,826	86,139
Other
Components of the loss before income taxes included in "Other"
Corporate expenses	(11,303)	(32,442)
Interest expense	(7,522)	(8,156)
Earnings from wholly-owned domestic distribution companies and other income, net	5,727	2,697
Earnings before income taxes	$ (13,098)	$ (37,901)

Revenue - Disaggregation by Maj

Revenue - Disaggregation by Major Product Type and Geographic Market (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Disaggregation of Revenue [Line Items]
Revenues	$ 872,986	$ 767,483
United States
Disaggregation of Revenue [Line Items]
Revenues	681,305	591,648
International Countries
Disaggregation of Revenue [Line Items]
Revenues	191,681	175,835
Equipment
Disaggregation of Revenue [Line Items]
Revenues	785,640	681,892
Irrigation
Disaggregation of Revenue [Line Items]
Revenues	87,346	85,591
Operating Segments | Professional
Disaggregation of Revenue [Line Items]
Revenues	650,223	594,721
Operating Segments | Professional | United States
Disaggregation of Revenue [Line Items]
Revenues	501,860	454,396
Operating Segments | Professional | International Countries
Disaggregation of Revenue [Line Items]
Revenues	148,363	140,325
Operating Segments | Professional | Equipment
Disaggregation of Revenue [Line Items]
Revenues	575,775	523,909
Operating Segments | Professional | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	74,448	70,812
Operating Segments | Residential
Disaggregation of Revenue [Line Items]
Revenues	217,700	165,848
Operating Segments | Residential | United States
Disaggregation of Revenue [Line Items]
Revenues	174,382	130,338
Operating Segments | Residential | International Countries
Disaggregation of Revenue [Line Items]
Revenues	43,318	35,510
Operating Segments | Residential | Equipment
Disaggregation of Revenue [Line Items]
Revenues	205,923	152,458
Operating Segments | Residential | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	11,777	13,390
Other
Disaggregation of Revenue [Line Items]
Revenues	5,063	6,914
Other | United States
Disaggregation of Revenue [Line Items]
Revenues	5,063	6,914
Other | International Countries
Disaggregation of Revenue [Line Items]
Revenues	0	0
Other | Equipment
Disaggregation of Revenue [Line Items]
Revenues	3,942	5,525
Other | Irrigation
Disaggregation of Revenue [Line Items]
Revenues	$ 1,121	$ 1,389

Revenue - Contract Liabilities

Revenue - Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Jan. 29, 2021	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Contract with customer, liability	$ 21.9	$ 21.9
Contract with customer liability revenue recognized	$ 2.5

Revenue - Performance Obligatio

Revenue - Performance Obligation (Details) $ in Millions	Jan. 29, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 7.5
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 6.8
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 5.1
Revenue, remaining performance obligation, expected timing of satisfaction, period

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets, Net - Changes in Net Carrying Amount of Goodwill (Details) $ in Thousands	3 Months Ended
	Jan. 29, 2021USD ($)
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	$ 424,075
Purchase price allocation adjustment	(1,027)
Goodwill divested	(1,534)
Translation adjustments	649
Goodwill, ending balance	422,163
Operating Segments | Professional
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	412,061
Purchase price allocation adjustment	(1,027)
Goodwill divested	0
Translation adjustments	518
Goodwill, ending balance	411,552
Operating Segments | Residential
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	10,480
Purchase price allocation adjustment	0
Goodwill divested	0
Translation adjustments	131
Goodwill, ending balance	10,611
Other
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	1,534
Purchase price allocation adjustment	0
Goodwill divested	(1,534)
Translation adjustments	0
Goodwill, ending balance	$ 0

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jan. 29, 2021	Jan. 31, 2020	Oct. 31, 2020
Other Intangible Assets
Weighted-Average Useful Life in Years	15 years 3 months 18 days	15 years 6 months	15 years 6 months
Gross Carrying Amount	$ 335,969	$ 309,254	$ 328,698
Accumulated Amortization	(116,025)	(95,937)	(110,905)
Net	219,944	213,317	217,793
Indefinite-lived - trade names	190,643	134,326	190,512
Total other intangible assets, gross	526,612	443,580	519,210
Total other intangible assets, net	410,587	347,643	$ 408,305
Estimated amortization expense
Amortization of other intangible assets	4,900	$ 4,700
Fiscal 2021	15,700
Fiscal 2022	19,300
Fiscal 2023	17,600
Fiscal 2024	16,500
Fiscal 2025	14,900
Fiscal 2026	14,200
After 2026	$ 121,700
Patents
Other Intangible Assets
Weighted-Average Useful Life in Years	9 years 10 months 24 days	9 years 10 months 24 days	9 years 10 months 24 days
Gross Carrying Amount	$ 18,275	$ 18,238	$ 18,257
Accumulated Amortization	(14,123)	(13,307)	(13,919)
Net	$ 4,152	$ 4,931	$ 4,338
Non-compete agreements
Other Intangible Assets
Weighted-Average Useful Life in Years	5 years 6 months	5 years 6 months	5 years 6 months
Gross Carrying Amount	$ 6,908	$ 6,875	$ 6,892
Accumulated Amortization	(6,851)	(6,798)	(6,831)
Net	$ 57	$ 77	$ 61
Customer-related
Other Intangible Assets
Weighted-Average Useful Life in Years	18 years 2 months 12 days	18 years 4 months 24 days	18 years 2 months 12 days
Gross Carrying Amount	$ 239,816	$ 220,364	$ 239,634
Accumulated Amortization	(51,747)	(36,970)	(48,005)
Net	$ 188,069	$ 183,394	$ 191,629
Developed technology
Other Intangible Assets
Weighted-Average Useful Life in Years	7 years 8 months 12 days	7 years 7 months 6 days	7 years 7 months 6 days
Gross Carrying Amount	$ 59,017	$ 51,902	$ 51,995
Accumulated Amortization	(36,230)	(32,264)	(35,208)
Net	$ 22,787	$ 19,638	$ 16,787
Trade names
Other Intangible Assets
Weighted-Average Useful Life in Years	15 years 3 months 18 days	15 years 4 months 24 days	15 years 4 months 24 days
Gross Carrying Amount	$ 7,563	$ 7,485	$ 7,530
Accumulated Amortization	(2,684)	(2,208)	(2,552)
Net	$ 4,879	$ 5,277	$ 4,978
Backlog and other
Other Intangible Assets
Weighted-Average Useful Life in Years	7 months 6 days	7 months 6 days	7 months 6 days
Gross Carrying Amount	$ 4,390	$ 4,390	$ 4,390
Accumulated Amortization	(4,390)	(4,390)	(4,390)
Net	$ 0	$ 0	$ 0

Indebtedness - Summary of Debt

Indebtedness - Summary of Debt (Details) - USD ($)	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Debt Instrument [Line Items]
Less: unamortized discounts, debt issuance costs, and deferred charges	$ 2,645,000	$ 2,855,000	$ 3,012,000
Total long-term debt	701,348,000	791,123,000	714,919,000
Less: current portion of long-term debt	(9,992,000)	(99,873,000)	(113,903,000)
Long-term debt, less current portion	691,356,000	691,250,000	601,016,000
Line of Credit
Debt Instrument [Line Items]
Long-term debt, gross		100,000,000	100,000,000
6.625% senior notes
Debt Instrument [Line Items]
Long-term debt, gross		123,978,000	123,931,000
Senior Notes | $200 million term loan
Debt Instrument [Line Items]
Debt instrument, face amount	200,000,000
Long-term debt, gross	100,000,000	100,000,000	100,000,000
Senior Notes | $300 million term loan
Debt Instrument [Line Items]
Debt instrument, face amount	300,000,000
Long-term debt, gross	180,000,000	180,000,000	180,000,000
Senior Notes | $190 million term loan
Debt Instrument [Line Items]
Debt instrument, face amount	190,000,000
Long-term debt, gross	$ 0	90,000,000	0
Senior Notes | 3.81% series A senior notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.81%
Long-term debt, gross	$ 100,000,000	100,000,000	100,000,000
Senior Notes | 3.91% series B senior notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.91%
Long-term debt, gross	$ 100,000,000	100,000,000	100,000,000
Senior Notes | 6.625% senior notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.625%
Long-term debt, gross	$ 123,993,000
Line of Credit
Debt Instrument [Line Items]
Long-term debt, gross	$ 0	$ 0	$ 14,000,000
Corporate Debt Securities | Seven Point Eight Percent Coupon Debentures
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.80%
Long-term debt, gross	$ 100,000,000

Indebtedness - Narrative (Detai

Indebtedness - Narrative (Details) $ in Millions	Jan. 29, 2021USD ($)
Debt Disclosure [Abstract]
Fiscal 2021	$ 0
Fiscal 2022	109
Fiscal 2023	18
Fiscal 2024	153
Fiscal 2025	0
Fiscal 2026	0
After fiscal 2026	$ 425

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 226,979	$ 168,759	$ 188,235
Finished goods and service parts	530,415	565,761	632,796
Total FIFO value	757,394	734,520	821,031
Less: adjustment to LIFO value	82,087	82,087	82,071
Total inventories, net	$ 675,307	$ 652,433	$ 738,960

Property and Depreciation - Nar

Property and Depreciation - Narrative (Details)	3 Months Ended
	Jan. 29, 2021
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	10 years
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	40 years
Equipment | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	2 years
Equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	15 years
Tooling | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Tooling | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Software and Software Development Costs | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	2 years
Software and Software Development Costs | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years

Property and Depreciation - Sum

Property and Depreciation - Summary (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 1,249,215	$ 1,240,158	$ 1,151,610
Less: accumulated depreciation	792,068	772,239	720,357
Property, plant, and equipment, net	457,147	467,919	431,253
Land and land improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	56,808	57,387	55,602
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	299,566	301,848	276,705
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	500,410	499,312	450,321
Tooling
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	231,728	231,142	216,541
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	102,357	102,312	94,385
Construction in process
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 58,346	$ 48,157	$ 58,056

Warranty Guarantees - Schedule

Warranty Guarantees - Schedule of Changes in Accrued Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Warranty provisions, claims, and changes in estimates
Beginning balance	$ 107,121	$ 96,604
Provisions	16,695	14,031
Claims	(15,186)	(14,703)
Changes in estimates	153	691
Ending balance	$ 108,783	$ 96,623

Investment in Finance Affilia_2

Investment in Finance Affiliate - Narrative (Details) - USD ($)	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020	Oct. 31, 2020
Schedule of Equity Method Investments
Total assets	$ 2,875,138,000	$ 2,491,609,000	$ 2,853,228,000
Red Iron Acceptance, LLC
Schedule of Equity Method Investments
Maximum aggregate amount of products repossessed by Red Iron and the TCFIF Canadian affiliate, entity has agreed to repurchase in a calendar year	7,500,000
Net amount of new receivables financed for dealers and distributors	511,300,000	405,100,000
Equity method investment summarized financial information, receivables, net	$ 13,100,000	29,500,000	12,600,000
Portion owned by Toro (as a percent)	45.00%
Portion owned by TCFIF (as a percent)	55.00%
Maximum borrowing capacity under credit facility	$ 625,000,000
Investment in joint venture	23,000,000	$ 25,500,000	$ 19,700,000
Equity Method Investment, Nonconsolidated Investee or Group of Investees | Red Iron Acceptance, LLC
Schedule of Equity Method Investments
Total assets	458,500,000
Total liabilities	$ 407,500,000

Stock-Based Compensation Plan_2

Stock-Based Compensation Plans - Compensation Costs Related to Stock-Based Awards Granted (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	$ 4,516	$ 3,960
Stock option awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	2,058	1,777
Performance share awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	827	548
Restricted stock unit awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	960	942
Unrestricted common stock awards
Stock-Based Compensation
Total compensation cost for stock-based compensation awards	$ 671	$ 693
Unrestricted common stock awards | Board of Directors
Stock-Based Compensation
Fully vested unrestricted common stock awards granted (in shares)	8,070	8,920

Stock-Based Compensation Plan_3

Stock-Based Compensation Plans - Stock Option Awards (Details) - Stock option awards - $ / shares	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Assumptions for options granted
Expected life of option in years	6 years 2 months 15 days	6 years 3 months 21 days
Expected stock price volatility (as a percent)	23.26%	19.38%
Risk-free interest rate (as a percent)	0.55%	1.79%
Expected dividend yield (as a percent)	0.86%	0.98%
Weighted-average fair value at date of grant (in dollars per share)	$ 19.38	$ 15.37
Tranche One | Board of Directors
Stock-Based Compensation
Vesting (as a percent)	33.33%
Tranche Two | Board of Directors
Stock-Based Compensation
Vesting (as a percent)	33.33%
Tranche Three | Board of Directors
Stock-Based Compensation
Vesting (as a percent)	33.33%

Stock-Based Compensation Plan_4

Stock-Based Compensation Plans - Performance Share Awards and Restricted Stock and Restricted Stock Unit Awards (Details) - $ / shares	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Performance share awards
Stock-Based Compensation
Performance goal period	3 years
Weighted-average fair value of awards granted (in dollars per share)	$ 90.59	$ 77.33
Performance share awards | Minimum
Stock-Based Compensation
Vesting (as a percent)	200.00%
Performance share awards | Maximum
Stock-Based Compensation
Vesting (as a percent)	0.00%
Restricted stock and restricted stock unit awards
Stock-Based Compensation
Weighted-average fair value of awards granted (in dollars per share)	$ 91.51	$ 77.08
Tranche One | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting (as a percent)	33.33%
Tranche Two | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting (as a percent)	33.33%
Tranche Three | Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting (as a percent)	33.33%

Stockholders' Equity - Componen

Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Accumulated other comprehensive loss (AOCL)
Foreign currency translation adjustments	$ 14,112	$ 24,508	$ 31,749
Pension benefits	5,106	5,106	4,861
Cash flow derivative instruments	12,958	4,648	(4,489)
Total accumulated other comprehensive loss	$ 32,176	$ 34,262	$ 32,121

Stockholders' Equity - Compon_2

Stockholders' Equity - Components and Activity of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	$ (1,114,828)	$ (859,578)
Other comprehensive (income) loss before reclassifications	(4,084)	1,609
Amounts reclassified from AOCL	1,998	(1,537)
Net current period other comprehensive (income) loss	(2,086)	72
Balance as of the end of the fiscal period	(1,179,722)	(912,050)
Accumulated Other Comprehensive Loss
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	34,262	32,049
Net current period other comprehensive (income) loss	(2,086)	72
Balance as of the end of the fiscal period	32,176	32,121
Foreign  Currency Translation Adjustments
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	24,508	31,025
Other comprehensive (income) loss before reclassifications	(10,396)	724
Net current period other comprehensive (income) loss	(10,396)	724
Balance as of the end of the fiscal period	14,112	31,749
Pension Benefits
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	5,106	4,861
Balance as of the end of the fiscal period	5,106	4,861
Cash Flow Derivative Instruments
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	4,648	(3,837)
Other comprehensive (income) loss before reclassifications	6,312	885
Amounts reclassified from AOCL	1,998	(1,537)
Net current period other comprehensive (income) loss	8,310	(652)
Balance as of the end of the fiscal period	$ 12,958	$ (4,489)

Per Share Data - Reconciliation

Per Share Data - Reconciliations of Basic and Diluted Weighted-Average Share (Details) - shares	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Basic
Weighted-average number of shares of common stock (in shares)	108,103,000	107,380,000
Assumed issuance of contingent shares (in shares)	19,000	43,000
Weighted-average number of shares of common stock outstanding — Basic (in shares)	108,122,000	107,423,000
Diluted
Weighted-average number of shares of common stock outstanding — Basic (in shares)	108,122,000	107,423,000
Effect of dilutive securities (in shares)	1,072,000	1,232,000
Weighted-average number of shares of common stock outstanding — Diluted (in shares)	109,194,000	108,655,000
Options, restricted stock, and restricted stock units, excluded from the diluted earnings per share (in shares)	268,778	262,205

Contingencies (Details)

Contingencies (Details) - Exmark Manufacturing Company Incorporated v. Briggs & Stratton Corporation $ in Thousands	Nov. 19, 2020USD ($)
Loss Contingencies [Line Items]
Litigation settlement, amount awarded to other party	$ 33,650
Litigation settlement, percentage of the settlement amount	50.00%

Leases - Lease Expense Incurred

Leases - Lease Expense Incurred (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Leases [Abstract]
Operating lease expense	$ 4,974	$ 4,834
Short-term lease expense	580	682
Variable lease expense	17	37
Total lease expense	$ 5,571	$ 5,553

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow and Other Lease Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Leases [Abstract]
Operating cash flows for amounts included in the measurement of lease liabilities	$ 4,682	$ 4,741
Right-of-use assets obtained in exchange for lease obligations	$ 293	$ 6,133

Leases - Summary of Other Lease

Leases - Summary of Other Lease Information (Details)	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Leases [Abstract]
Weighted-average remaining lease term of operating leases in years	6 years 10 months 24 days	7 years 1 month 6 days	6 years 2 months 12 days
Weighted-average discount rate of operating leases	2.78%	2.79%	2.81%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Operating Lease Payments (Details) $ in Thousands	Jan. 29, 2021USD ($)
ASC Topic 842 Leases
2021 (remaining)	$ 18,801
2022	15,910
2023	12,515
2024	11,044
2025	9,987
Thereafter	23,613
Total future minimum operating lease payments	91,870
Less: imputed interest	13,033
Present value of operating lease liabilities	$ 78,837

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details)	3 Months Ended
	Jan. 29, 2021USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Maximum length of time hedged in cash flow hedge	2 years
Cash flow hedge effectiveness measurement period	2 months
Gain (loss) from AOCL earnings	$ (11,600,000)
Forward currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, notional amount	$ 259,900,000

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Fair value of derivatives
Derivative assets:	$ 1,472	$ 933	$ 12,676
Derivative liabilities:	16,963	2,484	0
Forward currency contracts
Fair value of derivatives
Derivative assets:	1,472	933	12,676
Derivative liabilities:	16,963	2,484	0
Forward currency contracts | Derivatives designated as cash flow hedging instruments: | Prepaid expenses and other current assets
Fair value of derivatives
Derivative assets:	1,294	802	9,244
Forward currency contracts | Derivatives designated as cash flow hedging instruments: | Accrued liabilities
Fair value of derivatives
Derivative liabilities:	14,763	2,687	0
Forward currency contracts | Derivatives not designated as cash flow hedging instruments: | Prepaid expenses and other current assets
Fair value of derivatives
Derivative assets:	178	131	3,432
Forward currency contracts | Derivatives not designated as cash flow hedging instruments: | Accrued liabilities
Fair value of derivatives
Derivative liabilities:	$ 2,200	$ (203)	$ 0

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Effects of Master Netting Arrangements (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Derivative assets:
Net amounts of assets presented in the Condensed Consolidated Balance Sheets	$ 1,472	$ 933	$ 12,676
Derivative liabilities:
Net amounts of liabilities presented in the Condensed Consolidated Balance Sheets	(16,963)	(2,484)	0
Forward currency contracts
Derivative assets:
Gross amounts of recognized assets	1,472	1,139	12,841
Gross liabilities offset in the Condensed Consolidated Balance Sheets	0	(206)	(165)
Net amounts of assets presented in the Condensed Consolidated Balance Sheets	1,472	933	12,676
Derivative liabilities:
Gross amounts of recognized liabilities	(16,970)	(3,233)	0
Gross assets offset in the Condensed Consolidated Balance Sheets	7	749	0
Net amounts of liabilities presented in the Condensed Consolidated Balance Sheets	$ (16,963)	$ (2,484)	$ 0

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Impact and Location of Amounts Reclassified from AOCL and Impacts and Location on OCI (Details) - Cash flow hedging - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	$ (1,998)	$ 1,537
Gain (Loss) Recognized in OCI on Derivatives	(8,310)	652
Forward currency contracts | Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	(2,097)	1,205
Gain (Loss) Recognized in OCI on Derivatives	(7,694)	584
Forward currency contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	99	332
Gain (Loss) Recognized in OCI on Derivatives	$ (616)	$ 68

Derivative Instruments and He_7

Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Net sales	$ 872,986	$ 767,483
Cost of Sales	(557,950)	(479,395)
Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	(1,998)	1,537
Net Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Net sales	872,986	767,483
Cost of Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Cost of Sales	(557,950)	(479,395)
Forward currency contracts | Net Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	(2,097)	1,205
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value	162	660
Forward currency contracts | Cost of Sales | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) reclassified from AOCL into earnings	99	332
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value	$ 185	$ 11

Derivative Instruments and He_8

Derivative Instruments and Hedging Activities - Impact and Location of Derivatives Not Designated As Cash Flow Hedging Instruments (Details) - Other income, net - Derivatives not designated as cash flow hedging instruments: - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2021	Jan. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (3,478)	$ 220
Forward currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (3,478)	$ 220

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Assets:
Forward currency contracts	$ 1,472	$ 933	$ 12,676
Liabilities:
Forward currency contracts	16,963	2,484	0
Forward currency contracts
Assets:
Forward currency contracts	1,472	933	12,676
Liabilities:
Forward currency contracts	16,963	2,484	0
Measured on a recurring basis
Assets:
Total assets	1,472	933	12,676
Liabilities:
Total liabilities	16,963	2,484
Measured on a recurring basis | Forward currency contracts
Assets:
Forward currency contracts	1,472	933	12,676
Liabilities:
Forward currency contracts	16,963	2,484
Measured on a recurring basis | Level 1
Assets:
Total assets	0	0	0
Liabilities:
Total liabilities	0	0
Measured on a recurring basis | Level 1 | Forward currency contracts
Assets:
Forward currency contracts	0	0	0
Liabilities:
Forward currency contracts	0	0
Measured on a recurring basis | Level 2
Assets:
Total assets	1,472	933	12,676
Liabilities:
Total liabilities	16,963	2,484
Measured on a recurring basis | Level 2 | Forward currency contracts
Assets:
Forward currency contracts	1,472	933	12,676
Liabilities:
Forward currency contracts	16,963	2,484
Measured on a recurring basis | Level 3
Assets:
Total assets	0	0	0
Liabilities:
Total liabilities	0	0
Measured on a recurring basis | Level 3 | Forward currency contracts
Assets:
Forward currency contracts	0	0	$ 0
Liabilities:
Forward currency contracts	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Jan. 29, 2021	Oct. 31, 2020	Jan. 31, 2020
Assets and liabilities measured at fair value disclosures
Long-term debt, percentage bearing fixed interest, amount	$ 424	$ 424	$ 423.9
Level 2
Assets and liabilities measured at fair value disclosures
Long-term debt, fair value	$ 524.3	$ 508.2	$ 513.7